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Abstract
The purpose of this study was to examine the influence of psychosocial factors on drug court
graduation among a medication assisted treatment drug court population. The extant research identifies
drug courts as effective in reducing recidivism and relapse rates; however meta-analyses of the drug
court literature reveal that there is little explanation as to why drug courts are effectual and especially
for whom. This study examined trauma, mental health, and social support to determine predictive
psychosocial factors of drug court participants while controlling for certain demographics. The analyses
showed that social support was predictive, but failed to identify trauma or mental health correlates.
Policy implications are discussed.

vi

Chapter 1: Introduction
Individuals who become involved with the criminal justice system frequently engage in
substance abusing behaviors. The relationship between substance use and crime has been well
established (Andrews & Bonta 2010). Drug arrests account for the highest number of arrests in the
United States, with the criminal justice burden for processing these individuals increasing year after year
despite punitive policies aimed at reducing recidivism (Belenko, Fagin, & Chin, 1991). Empirical evidence
also establishes a relationship between mental illness and substance abuse (Frisher, Crome, Macleod,
Millson, & Croft, 2005; Steadman, Osher, Robbins, Case, & Samuels, 2009). Additionally, drug offenders
often report exposure to traumatic stress experiences over the course of their lifetime. These
experiences can lead to trauma-related disorders or other mental health symptoms (Subica, Claypoole,
& Wylie, 2012; Wu, Schairer, Dellor, & Grella, 2010). Individuals with mental illness and co-occurring
mental health and substance abuse disorders are disproportionally arrested and incarcerated at rates
higher than their counterparts in the justice system without mental health issues (Abram, Teplin, &
McClelland, 2003; Fazel & Danesh, 2002; Steadman, et al., 2009). A study by the Bureau of Justice
Statistics using national data found that 76% of jail inmates met criteria for mental illness and substance
dependence or abuse (James & Glaze, 2006). More recently, these groups are becoming increasingly
identified with the criminal justice system, and programs targeting these populations for diversion from
incarceration to supervised treatment are developing throughout the United States. Dedicated
interventions for justice-involved persons with co-occurring disorders or mental illness have
demonstrated effectiveness. Examples of these interventions are: pre- and post-booking diversion
programs, alternatives to sentencing programs such as pre-trial interventions, specialized probation,
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evidenced-based practices such as forensic intensive case management and assertive community
treatment, and specialty courts including drug courts and mental health courts.
The majority of criminological research on the drug-crime relationship has focused on patterns
of criminal activity among drug offenders, pathways to substance abuse, influence of delinquent peers,
racial contexts, desistance strategies, or the increase in incarceration rates in relation to legislative
efforts of the war on drugs (Baumer, 1994; Durlauf & Nagin, 2011; Krohn, Lizotte, Thornberry, Smith, &
McDowall; 1996; Mosher, 2001; Schroeder, Giordano, & Cernkovich, 2007; Spohn & Holleran, 2002).
Although these areas are worthwhile to study, criminological research has overlooked several issues
related to behavioral health. First, criminological studies of the drug-crime relationship often neglect the
issues surrounding effective treatment services or criminal justice alternatives for substance abusing
offenders and overlook possible interaction effects of psychosocial factors among substance abuse
populations. Empirical research on substance abuse and crime from a behavioral healthcare perspective
has identified mental illness and trauma as correlates of substance abuse and criminal justice
involvement (Carlson, Schafer, & Dufee, 2010; Green, Daroowalla, & Siddique, 2005; Johnson, Ross,
Taylor, Williams, Carvajal, & Peters, 2006; Messina, Grella, Burdon, & Prendergast, 2008). Justiceinvolved persons report higher rates of trauma than the general population (Beck, 2000; Hubbard &
Matthews, 2008; Miller & Najavits, 2012; Sarchiapone, Carlia, Cuomoa, Marchettia & Roy, 2008; CANYWomen in Prison Project, 2006). High rates of trauma exposure among substance abusing adults have
been reported as well (Acierno, 2003; Najavits, 2006; McCauley, et.al, 2009).
Along with its neglect of mental health and trauma effects on the drug-crime relationship,
criminal justice research has also overlooked shifting trends from, for instance, the crack cocaine
epidemic of the 1980s and 1990s to the current prescription drug epidemic (as defined by the Centers
for Disease Control) that extend beyond traditional drug-crime associations. Nonmedical prescription
drug use is quickly surpassing other substances as the most used substance among drug users, second
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only to marijuana use among individuals aged 12 and older in the United States (NSDUH, SAMHSA,
2011). Currently, persons aged 18-25 report the highest use of nonmedical prescription drugs and are
considered the most medicated generation in history (Apahall & Schwartz-Bloom, 2008; Quintero,
2005). Nevertheless, problems associated with the nonmedical use of prescription medication are
having far-reaching effects across demographic groups. Unfortunately, national data on arrest rates for
nonmedical prescription drug use are not available due to the manner in which drug arrests are
recorded. However, data from the National Drug Intelligence Center, which surveys law enforcement
agencies, indicate increases in gang activity related to the distribution of prescription medication,
increased arrests for possession of narcotics and other psychopharmaceutical drugs without a
prescription, increased illegal activities in the form of prescription fraud and doctor shopping schemes,
and associations between pharmaceutical diversion (criminal acts involving prescription drugs) and
property and violent crime (NDIC, NDTS, 2011). The consequences associated with the nonmedical use
of prescription drugs mirror those of other illicit drug use: risks of substance abuse and dependence
disorders, serious drug-related physical and mental health issues, increased risk factors for involvement
in criminal activity with subsequent arrests and incarceration, and decreased quality of life issues (family
disruption, loss of economic and educational opportunities and achievements) (McCabe, Cranford,
Morales, & Young, 2006).
A final issue often downplayed in traditional criminological research is the growing shift to
therapeutic jurisprudence over traditionally adversarial criminal justice responses that have had little
impact on fighting the war on drugs. Alternatives to incarceration (ATI) programs provide a method to
merge treatment with supervision. ATI provides the supervision warranted by the criminal behaviors of
substance abusing offenders while also providing treatment to improve the issues that led to the crimes
committed in order to support addiction or that resulted from problems related to addiction. Drug
court programs are an example of ATI that have demonstrated positive outcomes. The drug court
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model is an alternative method of criminal supervision that reduces the burden of drug crime on the
criminal justice system by utilizing mandated treatment in conjunction with close court supervision
(Hoffman, 1999; NADCIP, 2011, NIJ, 2006) to address drug addiction as the basis for criminal behavior.
Research findings support drug court effectiveness in terms of decreased rates of recidivism and
substance abuse relapses (Belenko, 2001; GAO, 2011; Gottfredson & Exum, 2002; Spohn, Piper, Martin
& Frenzel, 2001). Additionally, research has demonstrated the benefits of the drug court model in terms
of cost savings for both judicial processing and law enforcement activities (Huddleston, Marlowe, &
Casebolt, 2008). However, some researchers have argued that effective outcomes of the drug court
model are not clearly understood and that what works and how it works, and for whom, need further
attention (Belenko, 2001; Cisner & Rempel, 2005; Hoffman, 1999; Marlowe, Festinger, Lee, Dugosh, &
Benasutti, 2006).
One of the primary issues in drug court evaluation research involves variability in successful
completion of drug court programs. In order to better discern why drug courts work, an understanding
of factors associated with successful drug court graduation is necessary in order to make informed
decisions in the assessment, management, and treatment of justice-involved individuals with substance
abuse problems. A shortcoming of the extant literature on drug courts is the scarcity of research
examining psychosocial characteristics of drug court clients or a focus on treatment outcomes in relation
to these factors (Bouffard & Richardson, 2007; Hagedorn & Willenbring, 2003). Furthermore,
examination of drug court offenders who abuse prescription medication and the study of medicationassisted treatment programs within the drug court context are fundamental in addressing the serious
public health and criminal justice burden of the nonmedical use of pharmaceutical drugs.
A shift in the examination of the drug-crime relationship within criminology is needed to better
explore an interdisciplinary approach to addressing current issues surrounding substance abuse
offenders. To date, criminological research has not consistently or comprehensively evaluated
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psychosocial factors related to the drug-crime relationship within an interdisciplinary framework, nor
has there been an emphasis on investigating populations of nonmedical prescription drug users. Finally,
although criminologists have examined drug courts and questioned their structure and processes, there
is a lack of research on for whom drug courts work. A consideration within criminological research of the
drug-crime relationship as a significant behavioral health care problem with substantial criminal justice
and public health burdens is important, and further examination of drug court effectiveness in terms of
the populations it serves contributes to literature on individual level factors that influence program
completion.
An examination of psychosocial factors in relation to their contribution to negative or positive
substance abuse treatment outcomes could be beneficial in terms of identifying risk conditions as well
as protective factors for successful substance abuse treatment in criminal justice populations.
Psychosocial factors such as untreated mental health or trauma-related issues could negatively impact
treatment outcomes (Agerwala & McCance-Katz, 2012; Chan,Huang, Bradley, & Unutzer, 2013), whereas
psychosocial factors such as access to social support mechanisms could contribute to positive treatment
outcomes (Dobkin, De Civita, Paraherakis, & Gill, 2002). The prevalence of co-occurring disorders
among justice-involved persons and the potential barriers to treatment and recovery these disorders
present (Warren, Stein, & Grella, 2007) contribute to recidivism and enable the drug-crime relationship.
An examination of the relationship among psychosocial factors and treatment outcomes contributes to
the intersection of public safety and public health which could, in turn, influence decision making
practices within the criminal justice system, and drug courts in particular, to better assess individuals
who may be eligible for intervention programs and enhance management procedures within programs
to improve success (Cheesman, Rubio & VanDuisend, 2004). Since behavioral health disorders account
for more disability than any other medical problem (Council [SAMHSA], 2004) an emphasis on services
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and treatment could account for cost savings beyond the criminal justice sector and into the public
health sector.
Although drug courts have established efficacy for reducing recidivism and relapse rates among
adult substance abuse offenders (Belenko, 1998), the focus on crime reduction outcomes with limited
focus on mental health outcomes (National Institute on Drug Abuse, 2007) is problematic. Much of the
program evaluation research on drug court treatment outcomes focused on drug court processes and
while structural information is relevant, meta-analyses of the literature identified a lack of a clear
understanding as to how the processes are effective and for whom (GAO, 2005; Mitchell, Wilson, Eggers,
& MacKenzie, 2012; Shaffer, 2011; Wilson, Mitchell, & MacKenzie,2006); studies have failed to provide
an explanation as to why drug courts work for some populations and not others (Marlowe, et. al, 2006).
The literature demonstrates positive program characteristics (Huddleston & Marlowe, 2011) and
demographic characteristics that contribute to program completion (Bhati & Roman, 2010; Bouffard &
Richardson, 2007), but results are often mixed (Merrall & Bird, 2009; see Appendix A) and gaps in the
literature remain (Stinchcomb, 2010). The question has been do drug courts work and the answer is yes,
but the questions as to why and for whom remain ambiguous. Information on the psychosocial
characteristics of drug court participants could offer further explanation for the efficacy of drug court
treatment. Drug courts are designed to treat non-violent offenders who have committed drug offenses,
and while they do not explicitly address mental illness or co-occurring disorders as part of the key
components of drug court, it is not unlikely that drug court clients demonstrate mental health or
trauma-related symptoms given their prevalence rates among substance abusers. It would be both
appropriate and beneficial to develop informed assessment procedures within drug courts to assist with
the identification of current mental health symptoms and to direct effective trauma-informed care as
unmet mental health care needs are one of the most relevant issues for relapse. Identifying cooccurring, trauma-related disorders or current mental health symptoms, and providing relevant
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treatment, could better address the factors related to offending behaviors, which in turn could
contribute to better treatment outcomes as well as provide a better understanding as to why drug court
treatment works and for whom. Likewise, studying drug court populations that better represent current
trends in substance use patterns, i.e., offenders who abuse prescription medication, could contribute to
research that examines criminogenic risks (i.e., matching intensity of service to risk level) (Andrews
Bonta, 2010; Andrews & Dowden, 1999; Marlowe, et al., 2006).
The following study attempted to explore participant demographics and psychosocial factors
within a drug court context. Specifically, an examination of psychosocial factors as predictors of drug
court graduation was undertaken to determine the possibility of a negative relationship between
traumatic stress, mental health symptom severity, and program success. Also examined was the
possibility of a positive relationship between access to prosocial support systems and successful
program completion in terms of drug court graduation. The objective was to provide a better
understanding of how psychosocial factors influence successful or unsuccessful drug court graduation.
The hypotheses guiding this study were that exposure to traumatic stress and resulting mental health
symptoms would negatively impact successful drug court graduation and that access to prosocial
support systems would positively impact successful drug court graduation. In addition, this study
investigated these issues within a sample of prescription drug abusers assigned to medication-assisted
drug court treatment, a little studied population in criminological research. The results of this study
were intended to provide information regarding the relationship between psychosocial factors and drug
court graduation that may provide useful data to better understand for whom drug court works and to
possibly reveal important policy implications for addressing the needs of individuals with co-occurring
disorders within a criminal justice context. Finally, this study contributes to the literature by shifting the
focus from traditional drug-crime research to examining current trends using an interdisciplinary
perspective.
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Chapter 2: The Criminal Justice and Public Health Burdens of Substance Abuse
Substance abuse, in the forms of both the use of illegal drugs and the misuse of prescription
medication, is a pervasive problem in the United States, resulting in a multiplicity of issues for not only
the individual drug user, but also for family members, the community, and society as a whole. The
social impact of substance abuse has led to a multitude of policies, programs, and sanctions in an effort
to “fight the war on drugs”. These strategies have focused on predominately punitive measures in an
effort to deter illegal drug activities (manufacture, use/misuse, and distribution) (King, 2008). Drug
violations accounted for the largest increase in arrests between the 1980s to present day (Mauer & King,
2007a). In 2005, the largest proportions of arrests were for possession and distribution of illegal drugs,
with four out of five arrests being made for possession of illegal substances and one out of five arrests
being made for distribution of illegal substances (Belenko, 1998; Mauer & King, 2007b). According to
the FBI’s Uniform Crime Reporting (UCR) Program, law enforcement made an estimated 12,408,899
arrests nationwide in 2011; the highest number of arrests, 1,531,251 (8.1%), was for drug-related crimes
(UCR, 2011). Of the 1,531,251 arrests in 2011 for drug-related crimes, 1,252,563 (81.8%) were for
possession of a controlled substance.
Substance abuse tied to criminal justice involvement is not limited to illegal drugs; even with
federal and state level government regulations, the misuse and abuse of prescription medication is a
growing problem in the United States. Abuse of prescription medications including opiates,
benzodiazepines, stimulants, and other tranquilizers and sedatives is becoming more commonplace
(Becker, Fiellin, & Desai, 2007; Johnston, O’Malley, Bachman, & Schulenberg, 2006). Results of the
National Survey on Drug Use and Health (NSDUH, 2010-2011) found that 1 in 22 (4.5%) Americans age
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12 and older had taken a prescription medication for nonmedical purposes at least once in the year
prior to being surveyed (SAMHSA, 2011). The National Center on Addiction and Substance Abuse
(Califano, 2005) found that prescription drug abuse rates exceeded rates of cocaine use, heroin use, use
of hallucinogens, and use of inhalants combined. The harmful consequences of prescription drug abuse
have resulted in an increase in both fatal and non-fatal overdoses (Cai, Crane, & Poneleit, 2010). The
Drug Abuse Warning Network has estimated that approximately 25% of emergency room treatment
admissions for drug abuse are attributable to prescription drugs (Gibbs & Haddox 2003). The costs
associated with the nonmedical use of prescription opiates was estimated at $53.4 billion in 2006, with
criminal justice costs accounting for $8.2 billion (Hansen, Oster Edelsberg, Woody, & Sullivan, 2011).
The Coalition Against Insurance Fraud (2007) estimated the cost of the abuse of prescription pain
relievers at $72.5 billion. The Centers for Disease Control and Prevention has classified prescription drug
abuse as an epidemic, and several State and Federal policies have been implemented to address the
issue (prescription drug monitoring programs, Medicaid programs aimed at reducing doctor/pharmacy
shopping, training for law enforcement) (Paulozzi, Weisler, & Patkar, 2011). Many individuals who
abuse illicit drugs and/or misuse or abuse prescription medications are self-medicating untreated
psychological issues (Khantzian & Treece, 1985) or use drugs as a coping mechanism for dysphoria
(Mueser, Drake, & Wallach, 1998); these issues culminate in individuals engaging in criminal activities to
support their addiction. The legitimate uses of prescription drugs (i.e., pain management and substance
abuse treatment) affect criminal justice policies and create difficulties in combating misuses and abuse
(Schadelbauer & Katz [DEA}, 2001); however, arrest rates continue to climb for both illicit drug use and
prescription drug crimes (FBI: “Crime in the United States 2011”, 2012).
According to the Department of Justice Bureau of Justice Statistics (2007), the prison
population in the United States as of 2007 was 2,413,112. Research showed that more than 80% of
individuals incarcerated in state prison systems exhibited evidence of serious involvement with drugs
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and/or alcohol (Belenko & Peugh, 2005). Studies indicated that an estimated 95% of individuals
released from state prison systems with histories of drug abuse resume their drug use upon release
(Martin, Butzin, Saum, & Inicardi, 1999) and a large majority will be rearrested, reconvicted, and/or reincarcerated (Langan & Levin, 2002). Justice-involved individuals with mental illness and substance
abuse represent a large majority of the incarcerated population, with 76% of jail inmates accounting for
the highest rate followed by state prisoners (74%) and federal prisoners (64%) (James & Glaze, 2006).
To understand the impact of the drug-crime relationship, a consideration of factors other than
strictly drug violations in the criminal context is also important. According to Bureau of Justice Statistics
(2009) findings, 28% of individuals incarcerated at the federal level and 32% incarcerated at the state
level disclosed being under the influence of illicit drugs while committing their crime. Engagement in
criminal behavior could be considered as a means to support drug addiction. Furthermore, drug use
could influence motivations of individuals who commit crime (see for example, Goldstein, 1985). The
Substance Abuse and Mental Health Services Administration (SAMHSA) sponsors an annual measure of
drug use in the United States; the National Survey on Drug Use and Health (NSDUH) provides national
and state-level data on the use of tobacco, alcohol, illicit drugs (including non-medical use of
prescription drugs), and mental health (SAMHSA, NSDUH, 2011). According to the NSDUH, in 2011, an
estimated 22.5 million Americans aged 12 or older were current (past month) illicit drug users (SAMHSA,
NSDUH, 2011). Table 1 presents results of the 2011 NSDUH according to type of substance.
Table 1. Excerpts from the National Survey on Drug Use and Health 2011
Current users in past month aged 12 or older

Marijuana
Non-medical use of psychotherapeutic drugs
Non-medical use of pain relievers
Cocaine
Hallucinogens
Non-medical use of stimulants
Methamphetamine

Number of persons

18,100,000
6,100,000
4,500,000
1,400,000
972,000
970,000
439,000

Percentage of
population

7.0%
2.4%
1.7%
0.5%
0.4%
0.4%
0.2%
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Heroin
Source: NSDUH, SAMHSA, 2011

281,000

0.1%

Substance abuse is a complex social problem, and the best approaches to dealing with justiceinvolved substance abusing individuals have been argued for decades (Walker, 2006; Wilson &
Petersilia, 2002; Garland, 2001; Trebach & Inciardi, 1993). For many years, incarceration was considered
the most appropriate method, the focus being deterrence and punishment over rehabilitation (Wexler,
1994). Legislation was enacted for more severe sentences for drug offenders, attributable to societal
complaints about the lack of appropriate criminal justice responses to drug crimes (Wexler, 1994).
Certain research findings indicated that “nothing works” in terms of rehabilitation, which supported
demands for harsher punishments (Martinson, 1974; Warner & Kramer, 2009). Punishment strategies
have long been the primary means of drug crime prevention. However, the economic impact of these
“war on drugs” strategies is extensive, including increased costs to the judicial and criminal justice
systems, a loss of productivity in these sectors, enormous healthcare costs, and personal damages to
individuals and families in terms of housing issues (Caulkins & Sevigny, 2005; Mauer, 2003), barriers to
education (Mauer, 2003; Correctional Association, 2007), loss of income and healthcare benefits (NIDA,
1992), problems associated with entitlement benefits (Allard,2002), loss of parental rights, and loss of
voting rights (Sentencing Project, 2009) due to drug related arrests and incarcerations, and a drain to
social services including child safety investigations and foster care placements among other issues
(ONDCP, 2009).
The economic impact associated with drug control policies, particularly within the criminal
justice system, (i.e., law enforcement, judicial components, and corrections) coupled with the costs for
society (i.e., health care expenditures, productivity losses, and victimization costs), is enormous. In fact,
the National Drug Control Budget summary for fiscal year 2013 requested twenty billion dollars for
support in the areas of drug abuse prevention ($1.4 billion), treatment ($9.2 billion), and domestic law
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enforcement ($9.4 billion) (National Drug Control Strategy: FY 2013 Budget and Performance Summary).
According to the National Drug Intelligence Center (NDIC -U.S. Department of Justice), the economic
impact of illicit drug use in the United States in 2007 was $193,096,930. The NDIC (2011) estimates both
direct and indirect costs of substance abuse in three areas: crime costs, health costs, and productivity
costs. Each of the three principal areas are divided into many components – some of the results of the
2011 report by NDIC on the economic impact of substance use are presented in Table 2(NDIC, 2011).
Table 2. Economic Impact of Illicit Drug Use on American Society
Crime
Economic Impact
Criminal Justice System Costs
$56,373,254
Crime Victim Costs
$1,455,555
Other Crime Costs
$3,547,885
Total Crime Costs
$61,376,694
Productivity
Economic Impact
Labor Participation Costs
$49,237,777
Specialty Treatment Costs - State Level
$2,828,207
Specialty Treatment Costs - Federal Level
$44,830
Hospitalization Costs
$287,260
Incarceration Costs
$48,121,949
Premature Mortality Costs Non-homicide
$16,005,008
Premature Mortality Costs Homicide
$3,778,973
Total Productivity Costs
$120,304,004
Total Health Costs
$3,723,338
Source: NDIC, 2011
The problem of prescription drug abuse has an even greater burden. After a period of stability
of rates of treatment admission for substance use from 1999-2009 for most substances, rates of
treatment admission for opiate use increased by 430% over the same time period (SAMHSA, 2011).
According to the Drug Abuse Warning Network in 2011, there were over one million emergency
department (ED) visits for nonmedical use of prescription drugs (1, 244,872), which accounted for nearly
one quarter of all ED visits (26.4%) and half (50.5%) of all drug-related visits. From 2004 to 2011,
emergency room department visits related to the abuse or misuse of prescription drugs in the United
States increased for all pharmaceuticals by 132%; oxycodone (Oxycontin) related visits increased by
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263%, hydrocodone (Vicodin, Norco) related visits increased by 107%, hydromorphone (Dialudid)
related visits increased by 438%; and amphetamine-dextroamphetamine (Adderall) related visits
increased by 650% (Drug Abuse Warning Network, 2011).Conversely, a less than 1% increase was seen
for visits related to the use of methamphetamine, heroin, cocaine, and marijuana (Office of National
Drug Control Policy, 2010). According to the Centers for Disease Control and Prevention (2010), the
number of deaths due to unintentional overdose of opioid analgesics (prescription painkillers such as
Oxycontin and Percocet), were almost twice the number caused by cocaine and five times the number
caused by heroin in 2007; increases in the number of unintentional overdose deaths per year involving
opioid pain relievers increased nearly four times from 2,900 deaths in 1999 to 11,500 deaths in 2011
(CDC, 2011).
Despite punitive legislation and severe drug policies, drug crimes continue to increase along
with economic costs and social welfare burdens. An acknowledgment that the problems associated with
substance abuse could not be reconciled through punitive measures has resulted in the consideration of
alternative policies and practices to deal with drug offenders (Belenko, 2000). Some recent criminal
justice practices have revealed an emphasis on treatment over incarceration, and research has
supported a “what works” approach that has proven economic benefits (King & Pasquella, 2009).
Substance abuse treatment is one of the major efforts to reduce the societal costs associated with
substance abuse, particularly criminal justice costs (Harwood, Hubbard, Collins, & Rachal, 1988).
Substance abuse treatment, in both prison-based programs and community services, has evidenced
reductions in both substance use and recidivism among offender populations (Zanis, Mulvaney, Coviello,
Alterman, Savitz,& Thompson, 2003). There is a need for criminological research to incorporate a
behavioral health perspective that focuses on therapeutic justice and psychosocial factors to address the
problem of substance abuse. An interdisciplinary approach that emphasizes behavioral health may be
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even more important given current trends toward the nonmedical use of prescription drugs and the
subsequent criminal justice and public health burdens on society.
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Chapter 3: Substance Abuse and the Criminal Justice System: A Behavioral Health Perspective
The connection between substance abuse and crime is well established in the research
literature (Incardi, McBride & McCoy, 1997; MacCoun, Kilmer, & Reuter, 2003; MacKenzie & Uchida,
1994; Tonry & Wilson, 1990). Higher rates of substance abuse exist among justice-involved individuals
(arrestees, probationers, parolees, and those currently incarcerated) than among individuals who are
not justice- involved (ONDCP, 2009). Findings from the Arrestee Drug Abuse Monitoring program
revealed that 64% of male arrestees tested positive for at least one of five illicit drugs: (a) cocaine, (b)
opioids, (c) marijuana, (d) methamphetamines, and (e) phencyclidine (U.S. Department of Justice, 2000).
Criminal behaviors committed by individuals with substance use disorders can range in severity from
non-violent crimes such as possession or trespassing to more severe criminal acts such as prostitution,
driving under the influence, domestic violence, robbery, assault, and homicide (Bennett, Holloway, &
Farrington, 2008). The manufacture and distribution of illegal drugs and the misuse of legal drugs
(prescription medication) are also violations of the law that can lead to arrest and incarceration
(MacCoun, Kilmer, & Reuter, 2003; White & Gorman, 2000).
Substance abuse is considered a main criminogenic variable within the risk, need, responsivity
model of criminal behaviors and is predictive of recidivism (Dowden & Brown, 2002). Drug related
crimes coupled with tough on crime stances and policies related to the “war on drugs” have led to
increased incarceration rates in jails and prisons across the United States which, in turn, has introduced
a large number of offenders with substance use disorders, mental illness, and co-occurring disorders
into the criminal justice system (Breslau, Davis, & Schultz, 2003; Finn & Newlyn, 1997). Treatment
options for offenders with these problems are limited, and without access to appropriate behavioral

15

health protocols, this justice-involved population is likely to continue to cycle through the criminal
justice system (Center for Health Improvement, 2009).
With rising criminal justice costs and incarceration rates, federal and state criminal justice,
mental health care, and substance abuse agencies are examining more effective ways, including utilizing
system collaboration, to treat drug addiction among justice-involved populations in order to increase
the possibilities of moderating the drug-crime cycle. Pharmacotherapy or medication-assisted
treatment (MAT) is one treatment option with proven cost effectiveness and positive therapeutic
outcomes; however, MAT has been slow to be adopted within the criminal justice system (AMA, 2008).
MAT utilizes medication, such as methadone and buprenorphine in conjunction with counseling and
behavioral health services to combat addiction (SAMHSA, 2004). Many opponents to MAT consider it to
be substituting one substance for another when in actuality it is a safe and effective means to reduce
cravings and limit withdrawal symptoms, while regulating changes in brain chemistry for individuals on
maintenance programs (Nester & Malenka, 2004). Jails and prison officials are also reluctant to have
“drugs” in their institutions (ONDCP, 1999). However, research findings demonstrate MAT as the most
cost effective treatment modality for opioid addiction (CSAT, 2005). Offenders who received MAT while
incarcerated demonstrated positive outcomes while detained (total time served) and post-release
(decreases in recidivism rates) (Maremmani, Pacini, & Lovrecic, 2004). For offenders under community
supervision, research indicated that utilizing drug court treatment that includes medication as part of
the community-based treatment service reduces the risks of recidivism (continued criminal behaviors)
and relapse (reengagement of illicit and/or nonmedical use of prescription medication) (NIH, 1999;
Tomasino, Swanson, Nolan, and Shulman, 2001). Consideration of evidence-based medication-assisted
treatment by the criminal justice system as an effective component of rehabilitation is essential to
diminishing the drug-crime relationship.
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Therapeutic Jurisprudence: Drug Courts
The estimated societal costs of substance abuse was estimated at $190 billion annually and has
extensive repercussions for society as a whole beyond those experienced by the individual abusing
drugs (Office of National Drug Control Policy [ONDCP,2011). The criminal justice system bears the
greatest expense of substance abuse due to the costs surrounding adjudication and correctional services
(Butzin, Saum, & Scarpitti, 2002; Marlowe, 2010). In an effort to reduce costs associated with processing
and incarcerating individuals with not only substance abuse issues, but also mental health or cooccurring disorders and to break the cycle of incarceration due to behaviors associated with these
issues, several resourceful judicial solutions have been implemented throughout the United States. A
focus on a non-adversarial approach that considers the well-being of the offender and the issues that
led to their criminal disposition is the foundation of the legal philosophy known as therapeutic
jurisprudence (Wexler, 2001). Incorporating therapeutic approaches in criminal justice procedures
allows the legal process to attend to individual difficulties that, in turn, impact larger social problems.
Therapeutic jurisprudence encompasses such legal components as legislation, criminal justice
procedures such as diversion programs (both pre and post-booking), and judicial procedures such as
pre-trial interventions.
Therapeutic jurisprudence provides the foundation for drug courts, a judicial means to divert
non-violent offenders from traditional criminal justice practices of incarceration or standard probation
into treatment programs, thereby receiving treatment for substance abuse or co-occurring mental
health disorders that very likely contributed to their criminal justice involvement. Drug courts were
developed as instruments of change to address extra-legal factors that influence criminal behavior and
contribute to a revolving door of justice where specific groups of offenders regularly cycle in and out of
the justice system (Belenko & Dumanovsky, 1993). The initial formation of drug courts, although
experimental, was an innovative attempt to combat the greatly increasing correctional population while
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focusing on the offenders’ underlying issues that contribute to greater social problems. Drug courts
offer alternatives to incarceration that impact public safety and improve public health (National Institute
of Justice, 2006). The first drug court (DC) was implemented in Miami-Dade County, Florida in 1989;
currently, there are over 2,600 drug courts operating throughout the United States (National Institute of
Justice, 2012). Many of these specialty courts focus on specific populations of drug offenders such as
juveniles and veterans or have specific expectations such as family reunification (GAO, 1995; Goldkamp,
White, & Robinson, 2001; Schaffer, 2011; Wilson, Mitchell, & MacKenzie, 2006).
The drug court model operates under a fundamentally different set of standards than typical
criminal justice procedures; the prosecutor, defense attorney, judge, and other criminal justice
professionals (for example, probation officers) work together using a non-adversarial approach in an
effort to break the drug-crime cycle by providing an opportunity for the offender to receive treatment
and begin steps towards a prosocial lifestyle (Marlowe, 2003; National Drug Court Institute, 2000; OJP,
2006; Senjo & Leip, 2001). Drug court operations vary according to jurisdiction; however, the drug court
model follows a general principle in that it offers court-supervised substance abuse treatment for nonviolent offenders to remain in the community instead of being incarcerated in jail or prison. This
approach centers on two benefits. First, it provides a public health-focused intervention strategy for the
drug-crime relationship that incorporates close criminal supervision with substance abuse treatment as
a means to attend to addiction as the cause of criminal behaviors in an effort to reduce recidivism.
Second, the drug court approach reduces the burden of the criminal justice system (Hoffman, 1999;
Marlowe, et. al., 2006; NADCP, 2011; NIJ, 2006). Post-adjudication drug courts usually require a guilty
plea on the part of the defendant, with the understanding that successful completion of the program
will result in a suspended sentence, reduced charges, or a dismissal of charges and that failure to comply
will result in prosecution (Brown, Allison, Nieto, 2011;King & Pasquarella, 2009). Some drug courts
operate under a deferred prosecution model where defendants are not required to plead guilty; under
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this type of drug court, jail or prison diversion is offered for first time offenders with the same outcome
of prosecution for non-compliance (King & Pasquarella, 2009; Turner et al., 2002). Both postadjudication and deferred prosecution drug court models usually allow successful graduates to follow
procedures to have their records expunged (Nolan, 2002).
Drug courts provide community-supervised substance abuse treatment as an alternative to
incarceration for specified treatment lengths depending on jurisdiction; treatment duration ranges from
six to eighteen months, with the majority of drug court clients participating in drug court for one year
(National Center for State Courts, 2011) The drug court team typically involves the judge, district
attorney, defense counsel, drug court coordinator, substance abuse treatment provider, and sometimes
a probation officer or other law enforcement official, and/or a social services representative. The judge
is the principal member of the drug court team and provides not only sanctions for non-compliance, but
also rewards and encouragement for compliance (Harvard Law Review, 1998; NADCP, 1997). Drug court
clients (usually labeled as such to avoid terms like “offender” since this is a non-adversarial treatmentbased approach) are required to participate in court mandated substance abuse treatment, submit to
regular drug screens, and attend regularly scheduled drug court appearances to discuss progress
(NADCP, 1997). Additional requirements for drug court clients vary by jurisdiction, but can include
required parenting classes, completion of GED or vocational programs, community service, paying child
support, or obtaining employment, among other things (National Drug Court Resource Center, 2012).
Key components of drug courts according to the National Bureau of Justice Assistance in collaboration
with the National Association of Drug Court Professionals are presented in Table 3.
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Table 3. Ten Key Components of Drug Court
Component
1.

Drug court integrates alcohol and other drug treatment services with justice system case
processing.

2.

Using a non-adversarial approach, prosecution and defense counsel promote public safety while
protecting participants’ due process rights.

3.

Eligible participants are identified early and promptly placed in drug court.

4.

Drug court provides access to a continuum of alcohol, drug and other related treatment and
rehabilitative services.

5.

Abstinence is monitored by frequent alcohol and other drug testing.

6.

A coordinated strategy governs drug court responses to participant’s compliance.

7.

Ongoing judicial interaction with each drug court participant is essential.

8.

Monitoring and evaluation measure the achievement of drug court goals and gauge effectiveness.

9.

Continuing interdisciplinary education promotes effective drug court planning, implementation,
and operations.

10.

Forging partnerships among drug court, public agencies, and community-based organizations
generates local support and enhances drug court effectiveness.

Source: OJP, 2004
Drug offenders who participated in specialty courts have been found to be more likely to abstain
from substance use and to be less likely to be re-arrested than drug offenders in standard probation
(Banks & Gottfredson, 2003, 2004; Deschenes, Ireland, & Kleinpeter,2009; Gottfredson, Najaka, &
Kearly, 2003; Gottfredson, Kearly, Najaka, & Rocha, 2007; Roman, Townsend, & Bhati, 2003; Shaffer,
2011; Wilson, et al., 2006). Although much of the research supports the notion that treatment is more
likely than traditional forms of adjudication that do not involve treatment to reduce future criminal
behaviors among justice-involved substance abusers (Dynia & Sung, 2000; Goldkamp, White, &
Robinson, 2001; Spohn & Piper, 2004; Taxman & Bouffard, 2005; Wilson, Mitchell, & MacKenzie, 2006),
questions remain as to what types of treatment work best for which types of offenders (Arabia, Fox,
Caughie, & Marlowe, 2008; Festinger, Marlowe, Lee, Kirby, Bovasso & McLellan, 2001;Marlowe,
DeMatteo, & Festinger, 2004; Taxman & Bouffard, 2005).
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Criticism in regard to the research on drug courts identifies two problem areas: insufficient
evaluation of drug court procedures and outcomes and methodological issues with drug court studies
(Belenko, 2001; Cissner & Rempel, 2005; Finn, 2006; Goldkamp, White, & Robinson, 2001; Shaffer et al.,
2010; Turner et al., 2002). For example, in a review of adult drug court research by the Government
Accountability Office (GAO) in 2005, only 27 of 117 (23.8%) evaluations of drug court programs were
considered to be based on sound methodology (GAO, 2005). The lack of methodologically sound
evaluations leaves many remaining questions as to why drug courts work (NDCI, 2006).
In a report that summarized findings from federally funded drug courts, the GAO (2011),
established that recidivism rates were lower among drug court participants than among comparison
groups. However, there is no standard definition of recidivism within the drug court outcome literature:
some studies define recidivism as new arrests (Belenko, 2001, Gottfredson & Exum, 2002; Roman,
Townsend, & Bahti, 2003; Spohn, et al, 2001), some define recidivism as new convictions (Spohn, et al.,
2001), and other studies define recidivism as new court appearances (Miethe, Lu, & Reese, 2000).
Furthermore, the time at which recidivism is measured also varies: some studies measure recidivism
during drug court (Belenko, 2011; Gottfredson & Exum, 2002); others measure post-drug court
graduation recidivism rates (Miethe, et al, 2000; Spohn, et al., 2001), and some studies measure time to
recidivism (Spohn, et al, 2001).
Studies on relapse rates of drug court participants encounter the same lack of a standardized
definition of relapse, timeframes of relapse, and how relapse is reported (self-report vs. official data,
i.e., urinalysis). In a continuation study of previous research, Gottfredson et al. (2005) utilized selfreport data as a measure of relapse and found that drug court participants reported less drug use in the
past year than individuals assigned to standard adjudication. The GAO (2011) also indicated that drug
court participants were less likely to use drugs than those persons in comparison groups; 56% of drug
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court graduates reported drug use as compared to 76% of non-drug court offenders; this report
measured both self-reported drug use and urinalysis results.
Overall, outcome studies of drug court completion indicated that certain demographic and
criminogenic features affect drug court graduation rates, with drug court graduation correlates including
gender, race, age, marital status, level of education, employment status, criminal history, drug of choice,
and various drug court characteristics or operations, such as length of time the drug court has been in
operation and sanctions applied to the participant. However, much of the literature demonstrates
mixed results or contradictory findings (see Appendix A). For example, many studies find no differences
between men and women drug court participants in terms of graduation rates (Evans, Li, & Hser, 2009;
Hepburn & Harvey, 2007; Marlowe et al, 2003; Seachrest & Shicor, 2001; Senjo & Leip, 2001). In
contrast, Belenko’s (2001) review of drug court programs found that some studies indicated that men
were more likely to complete drug court treatment, but that women were more likely to demonstrate
positive outcomes during treatment. One explanation for this gender difference is that women
experience more gender-specific issues than men that may interfere with their capability of meeting
drug court program requirements, such as having primary caregiver duties that prevent them from
attending required meetings (Neal, 2010). Bouffard and Richardson (2007) noted that although
outcome studies provide evidence that drug courts work, the research reveals contradictory results in
terms of personal characteristics of drug court participants that fail to account for specific issues that
impact drug court completion. Their review of the literature indicates that while some research notes
certain characteristics such as age to be a predictive factor for completion, other research indicated that
the same characteristic results in higher dropout rates (Bouffard & Richardson, 2007).
Outcome study findings in regard to age also present contradictory findings, with some research
indicating no difference in drug court graduation according to the age of participants (DeMatteo,
Marlowe, Festinger, & Arabia, 2009; Gallagher, 2013; Shaffer et al., 2010) and others demonstrating a
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relationship between age and drug court completion (Cissner & Rempel, 2005; Hickert, Boyle &
Tollefson, 2009; Young and Belenko, 2002). Still other studies show that age does predict drug court
completion, but that directionality matters. For example, in terms of the effect of age on drug court
graduation, Hepburn and Harvey’s (2007) study found that older drug court participants were more
likely to graduate than younger participants; this finding is supported by other research (Hartley &
Phillips, 2001, Hickert, Boyle & Tollefson, 2009). Conversely, Senjo and Leip’s (2001) study found that
younger participants were more likely to complete drug court treatment. These studies demonstrated
age as a predictive factor of completion, but failed to account for why age is a factor given that age
effects varied across studies.
Studies that examined race as a correlate of drug court completion also found mixed results,
with a number of studies indicating that white/Caucasian drug court participants were more likely to
complete drug court than participants of other races (Belenko, 2001; Hepburn & Harvey, 2007; Schiff &
Terry, 1997; Senjo & Leip, 2001). Other studies found no difference among races in relation to drug
court graduation rates (Evans et al., 2009; Peters, Haas & Murrin, 1999). One explanation for this
contradiction is that although race can be a factor in drug court completion, other factors can interact
with race to influence outcomes (Rempel & DeStefano, 2001; Schaeffer, et. al, 2010).
Studies that examined education had similar contradictory outcomes. Some studies found that
level of education was positively related to drug court completion (DeMatteo et al., 2009; Hepburn &
Harvey, 2007; Hickert, Boyle, & Tollefson, 2009; Schaeffer et al., 2010; Mullany & Peat, 2008; Schiff &
Terry, 1997), while others found no effect (Senjo & Leip, 2001; Hiller, Knight, & Simpson, 1999). In a
study by Hickert, Boyle, and Tollefson (2009), the likelihood of successful drug court graduation
increased by 15% for each increase in grade level for education attainment. Other studies have found
that high school graduates were more likely to successfully complete drug courts when compared to
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participants who did not graduate high school or earn their GED (Gray & Saum, 2005; Mullaney & Peat,
2008).
In response to questions regarding contradictory findings of drug court evaluation research,
some authors note that interaction effects among program variables or individual level characteristics
limit the ability to predict program outcomes and that all findings should be considered cautiously, as
results from one drug court evaluation may not be generalizable to all drug courts (Belenko, 2001;
Marlow et al., 2004). Despite challenges in assessing the factors that contribute to effective drug
courts, there is empirical support that the drug court model reduces recidivism (Banks, & Gottfredson,
2004; Peters & Murrin, 2000; Listwan, Shaffer, Hartman, 2009) and demonstrates positive treatment
effects (Lowenkamp, Holsinger, & Latessa, 2005; Wilson, Mitchell, & Mackenzie, 2006). Furthermore,
more than one million participants have successfully completed drug court treatment programs (Nolan,
2008). Although there are legitimate methodological issues with drug court outcome studies, there is
evidence indicating that drug courts effectively reduce recidivism and relapse regardless of definition or
timeframe (Sanford & Arrigo, 2005; Roman, Townsend, & Bahti, 2003). However, research findings on
recidivism rates or relapse measures offer little explanation of the characteristics of the participants in
these programs to provide a more comprehensive understanding of who successfully completed drug
court treatment and why. A determination of whether there are predictable differences between drug
court participants who successfully completed mandated treatment and those who do not would better
answer questions about how and why drug courts work. A focus on individual level correlates such as
mental health, traumatic experiences, and social support could contribute to a more distinctive
determination of predictors of drug court completion.
Mental Health Symptoms, Substance Abuse, and Drug Courts
The extant literature on drugs and crime indicates that substance abuse, mental health
symptoms, and criminal behaviors both independently and in conjunction with one another expend a

24

severe social cost for Americans (Levinthal, 2008; Nocon, Berge, Astals, Martin-Santos, & Torrens (2007).
The Substance Abuse and Mental Health Services Administration (SAMHSA, 2010) estimates that up to
10 million adults experience co-occurring mental health and substance use disorders in any given year;
the term co-occurring disorder (COD) refers to co-occurring substance use (e.g., abuse or dependence)
and mental health disorder (DSM-IV-TR, 2000). Co-occurring disorders are diagnosed independently,
and clinicians rule out the possibility of multiple symptoms resulting from a single disorder (CSAT, 2006).
Research has demonstrated that individuals with mental illness are at greater risk for
developing a substance use disorder (Drake et al., 2001; Gil-Rivas, Grella, & Prause, 2009). Clinical
studies found that up to 75% of clients had lifetime co-occurring disorders (CSAT, 2007). Individuals
suffering from mental illness experience higher arrest rates than individuals without mental illness and
are disproportionately represented in incarcerated populations (Baillargeon, Penn, Knight, Harzke,
Baillargeon & Becker, 2009; Lamb & Weinberger2005; Steadman & Naples, 2005; National GAINS
Center, 2001). Many reasons exist for this overrepresentation; however, for most justice-involved
individuals with mental illness, the main reason for incarceration is a lack of access to mental health
services or other appropriate resources (Cobb, 2006; Draine & Herman 2007, Drapkin, 2003; NTAC,
2002). Steadman et al. (2001) reported that prevalence rates of serious mental illness among jail
inmates was estimated at over 7%; this is 2 to 3 times higher than prevalence rates of serious mental
illness found in the general population. Legislative policies such as mandatory sentencing and three
strikes laws have also, unintentionally, contributed to higher rates of incarceration of mentally ill or cooccurring offenders (Hartwell, 2004). Research findings for co-occurring disorders among incarcerated
populations mirror those of clinical studies, indicating that 75% of inmates have co-occurring disorders
(National GAINS Center, 2001). A report by the Department of Justice (DOJ, 2006) stated that many
justice-involved persons with mental illness have treatable disorders such as major depression, bipolar
disorder, and substance use disorders. However, correctional institutions are ill-equipped to properly
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address the mental illness and substance use treatment needs of inmates. Although the majority of
federal (94%) and state (82%) institutions provided some type of substance abuse treatment (SAMHSA,
2002), many justice-involved individuals go without mental health treatment altogether or without
proper integrated treatment for co-occurring disorders that accurately address their issues (DOJ, 2006;
Roskes & Feldman, 1999). Unfortunately, jails and prisons have become the main provider of mental
health and substance abuse services despite limited capabilities and resources to address the needs of
the mentally ill (SAMHSA, 2002 & APA, 2008). Regrettably, due to deinstitutionalization, there are more
persons with serious and persistent mental illness who are incarcerated in jails or prisons than in state
hospitals (Daniel, 2007).
Findings from the National Survey on Drug Use and Health (SAMHSA, 2011) indicate that among
the 18.9 million adults in America with substance use disorder in the past year, 42.3% had a co-occurring
mental illness; among those adults without a substance use disorder, 17.6% had a mental illness. In
2011, adults with a mental illness in the past year (25.2%) were more likely to use illicit drugs than adults
who did not have a mental illness in the past year (11.2%) (SAMHSA, 2011). This pattern was similar
across various types of substance use, including the use of marijuana, cocaine, heroin, hallucinogens,
and the nonmedical use of prescription medications. Substance use among adults with mental illness in
the past year was highest among those with serious mental illness (31.3%), moderate mental illness
(27.3%), and mild mental illness (21.7%), as compared to substance use among adults without mental
illness in the past year (11.8%) (SAMHSA, 2011). Mental illness (which typically goes undiagnosed until
well into adulthood) most often precedes substance use disorders (Kessler, 2004; Kessler, Berglund et
al., 2005); substance abuse may be a means to cope with untreated mental illness or as a mechanism to
deal with painful life experiences that may be attributed to an underlying mental illness (i.e.,
stigmatization, social isolation, poverty, and homelessness) (Henwood & Padgett, 2007; Laudet, Magura,
Vogel, & Knight, 2004). The National Survey on Drug Use and Health (NSDUH) found that 10.8 million
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adults (4.6%) reported an unmet need for mental health care in the past year; 45.4% of these individuals
(4.9 million adults) did not receive any type of mental health services in the past year (SAMHSA, 2011).
The consequences of untreated mental illness and co-occurring disorders may result in a decrease in
quality of life, problematic interpersonal relationships, job loss, exposure to trauma and violence,
homelessness, and criminal justice involvement (SAMHSA, 2011).
Gil-Rivas, Grella and Prause’s (2009) study of individuals with co-occurring disorders found that
a significant number of adults entering substance abuse treatment met criteria for co-occurring
disorder; individuals with co-occurring disorder had higher rates of recent hospital admissions
(psychiatric and medical) and reported more severe psychosocial functioning problems compared to
individuals without co-occurring disorders (substance use only) (Gil-Rivas et al., 2009). Gil-Rivas et al.
(2009) also established that a large majority of participants experienced trauma and that 35% met
criteria for PTSD. Results of this study indicated that traumatic experiences and symptoms of
depression and anxiety were associated with an increase in substance use after residential treatment.
Research has also found a relationship between mental health symptoms and nonmedical
prescription drug use (NMPDU) (Becker, Fiellin, & Desai, 2007; Becker, Sullivan, Tetrault, Desai, &
Fiellen, 2008; O’Brien, 2005; Sullivan, Edlund, Steffick, & Unutzer, 2005), particularly associations
between NMPDU and depression (Conway, Compton, Stinson, & Grant, 2006), NMPDU and suicidality
(Vidourek, King, & Knopf, 2010), and NMPDU and panic disorder, anxiety disorders, and phobias (Huang,
et al., 2006). Individuals suffering from posttraumatic stress disorders are at an increased risk for
nonmedical prescription drug dependence (Chilcoat & Breslau, 1998a, 1998b; Tetrault, Desai, Becker,
Fiellin, Concato, & Sullivan, 2008). The motivations for nonmedical use of prescription drugs are
comparable to the motivations for other illicit drug use, particularly the self-medication hypothesis (Ford
& Schroeder, 2009, McCabe, Boyd, & Teter, 2009; Wu, Pilowsky, & Patkar, 2008). In fact, those
individuals who choose prescription drugs over other illicit drugs in order to self-medicate report doing
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so because of the perceived safety (medicine), dose-response predictability (desirable and undesirable
effects are known based on dosage), and the pharmacological specificity (known therapeutic effect for
specific symptoms) (Cicero, Inciardi, & Munoz, 2005; Quintero, 2009; Quintero, Peterson, & Young,
2006; Volkow & Swanson, 2003). However, the use of prescription medications without the supervision
of a medical professional is dangerous, and individuals who misuse or abuse prescription medication are
at an increased risk for accidental overdose, dangerous interactions with other illicit drugs, poisoning
that can lead to death, suicidal thoughts or actions, adverse withdrawal symptoms, and tolerance that
can lead to increased use and dependence (Hearn, Rose, Wagner,Ciarleglio, & Mash, 1991; Hernandez &
Nelson, 2010; SAMHSA, 2004). Understanding psychosocial factors such as mental health correlates of
NMPDU is important for targeting criminal justice screens for substance abusing offenders who may
benefit from specialized treatment modalities that target specific needs.
Research on the effects of mental health correlates on drug court graduation is limited, but also
demonstrates mixed findings. Some studies found no relationship between mental health and drug
court outcomes (Dematteo, Marlowe, Festinger, & Arabia, 2009; Cosden, et al, 2006). Other studies did
find associations between mental health factors and drug court outcomes (Cissner& Rempel , 2005;
Evans, Li, & Hser, 2009;Garrity, et al, 2007; Gray & Saum, 2005; Hickert, et al, 2009; Mendoza, Trinidad,
Nochajaski, & Farrell, 2013). Gray and Saum (2005) examined the relationship between mental health,
gender, and drug court completion and found that gender (women), race (white), and education (higher
levels) were positively correlated with drug court graduation, but that depression, being prescribed a
medication for mental health problems, and drug use severity were negatively correlated with drug
court graduation. The authors suggest that assessing for mental health symptoms at the time of
treatment admission would allow for coordinated services aimed at improving clients’ mental health
that could subsequently impact treatment progress and increase the likelihood of successful drug court
graduation. The findings of Cissner and Rempel’s 2005 study indicate that drug court participants with
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co-occurring disorder are less likely to complete drug court than those participants without a mental
health diagnosis. Additionally, studies have shown that mental health issues are associated with
program incompletion or failure. Evans, Li, & Hser (2009), found that psychiatric conditions measured
with the Addiction Severity Index were more prevalent among non-completers than by those individuals
who completed drug court. Hickert, Boyle, and Tollefson (2007) found that drug court participants who
experienced symptoms of depression were more likely to drop out of treatment than those without
symptoms. Finally, Hiller, Knight, and Simpson (1999) found that symptoms of depression, anxiety, and
hostility were positively associated with program dropout.
Many studies examine the relationship between mental health and substance abuse (Jacobsen,
Southwick, & Kosten, 2001; Hein, Zimberg, Weisman, First, & Ackerman, 1997; Subica, Clypoole, &
Wylie, 2012; Triffleman, 2003; Triffleman, Marmar, & Ronfeldt, 1995), substance abuse treatment
outcomes in relation to mental health (Ford, Hawke, Alessi, Ledgerwood, & Petry, 2007; Hein, Nunes,
Levin, & Fraser, 2000; Ouimette, Finney, & Moos, 1999; Ouimette, Brown, & Najavits, 1998; Petersen, &
Zettle, 2009; Schaffer & Najavits, 2007), and treatment models for substance abuse and mental health
(Addictions and Trauma Recovery Integration (ATRIUM) [Miller & Guidry, 2001]; cognitive behavioral
therapy [Mueser & Fox, 2002; Brady et al., 2001; Donovan et al., 2001]; Seeking Safety [Najavits, 2002,
2007]; Substance-Dependence-Posttraumatic Stress Disorder Therapy [Triffelman, 2000]; Trauma
Recovery Empowerment Model [Fallot & Harris, 2002]; The Triad Women’s Project [Clark & Fearday,
2003] ). However, the research on mental health and drug court outcomes is sparse (Hagedorn &
Willenbring, 2003; Garrity, Prewitt, Joosen, Tindall, Webster, & Leukefeld, 2008). More research is
needed to examine the relationship between mental health symptoms and drug court outcomes. A
better understanding of individual characteristics that could impact successful drug court completion
could lead to more effective assessment and treatment interventions targeting specific needs of drug
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offenders and/or specific populations experiencing co-occurring disorders (i.e, veterans or domestic
violence or sexual assault survivors).
Trauma, Substance Abuse, and Drug Courts
Similar to the effects of mental health disorders, traumatic stress experiences may produce
considerable and persistent effects on functioning that can lead to maladaptive coping mechanisms such
as substance abuse or dependence. Individuals who experience traumatic stress events in their lifetime
may develop trauma-related symptoms that can result in diagnoses of trauma-related disorders such as
posttraumatic stress disorder (PTSD) and Acute Stress Disorder (ASD) (Breslau, Davis, & Schultz, 2003;
Brown, Campbell, Lehman, Grisham, & Mancill, 2001; Khoury, Tang, Bradley, Cubells,& Ressler, 2010).
Long term effects of trauma may also manifest in symptoms of anxiety and depression (Ford, Courtois,
van der Hart, Nijenhuis, & Steele, 2005; Johnson, Cohen, Brown, Smailes, & Bernstein, 1999).
Additionally, traumatic stress experiences may result in a variety of other internalizing and externalizing
behaviors, particularly substance abuse (Breslau, Davis, Peterson, & Schultz, 2000; Stewart, Pihl, Conrod,
& Dongier, 1998; Sacks, McKendrick, & Banks, 2008). Recent studies related to substance abuse
treatment advised that a lack of trauma assessment and subsequent trauma-informed care when
appropriate may result in less comprehensive treatment, consequently decreasing rates of prolonged
abstinence after substance abuse treatment completion (Covington, 1999; Hodges, 2003; Najavits, 2003,
2007).
Many symptoms of substance abuse can be associated with the long-term effects of trauma,
such as nightmares, mood swings, irritability, and experiencing extreme highs and lows (Covington,
1999); other common symptoms among substance use disorders and trauma are depression, anxiety,
and substance abuse (Brier, 1992). Common mental health problems among individuals in substance
abuse treatment that may affect treatment outcomes are: anxiety, depression, eating disorders,
posttraumatic stress disorder, trauma histories, and suicide attempts (Broner et al., 2002; Haywood et
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al., 1995; Henderson, 1998; Owen, 1999; Peters & Hills, 1999; Teplin, Abram, & McClelland, 1996).
Individuals who have experienced trauma at any time in their lives are more likely to develop mental
health issues and substance use disorders, and many go without treatment for these issues, which may
affect their overall functioning (Alexander, 1996; Goodman, Rosenberg, Mueser, & Drake, 1997; CSAT,
2009). Individuals with histories of traumatic stress experiences have a higher likelihood of substance
abuse. Their use of drugs and alcohol can be a method of self-medicating to alleviate symptoms
associated with trauma and mental illness (Covington, 1999; Najavits, 2004) or as a means to cope with
negative feelings associated with or disturbing memories of their trauma (Coffey, Stasiewicz, Hughes, &
Brimo, 2006; Najavits, 2007). Trauma is not always addressed in substance abuse treatment, since the
focus is on relapse prevention (Hightower, Smith, & Hightower, 2006; Walsh et al., 2007). However,
given the strong association between trauma and substance abuse (Brady, Back, & Coffey, 2004;
Chilcoat & Breslau, 1998; Chilcoat & Menard, 2003; Dansky, Saladin, Brady, Kilpatrick, & Resnick, 1995;
Hien, Cohen, & Campbell, 2005; Karadag, Sar, Tamar-Gurol, Evren, Karagoz, & Erkirian, 2005; Read,
Brown, & Kahler, 2004), a key component to successful treatment outcomes may require addressing the
trauma.
National prevalence rates for experiences of potentially traumatic events in adults over their
lifetime range from 65-80% (Roberts, Gilman, Breslau, Breslau, & Koenen, 2011). Men are more likely
than women to experience combat or accident related trauma and women are more likely to experience
victimization or the loss of loved ones (Pietrzak, Goldstein, Southwick, & Grant, 2011). Women and men
with traumatic stress experiences are more likely to abuse substances (Kilpatrick, Acierno, Resnick,
Saunders, & Best, 1997) and are more likely to exhibit symptoms that may affect treatment outcomes
such as depression and anxiety (Kessler, Sonnega, Bromet, Hughes, & Nelson, 1995).
Research on the association between trauma and the nonmedical use of prescription
medication is scarce, with relatively few studies examining this area. However, the limited findings do
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indicate a link between opioid use and psychological distress (Jamison, Butler, Budman, Edwards &
Wasan, 2010; Sung, Richter, Vaughan, Johnson, & Thom, 2008). Manchikianti and colleagues (2007)
examined psychological factors in opioid and illicit drug use in chronic pain patients and found increased
drug abuse among those patients with higher rates of depression, anxiety, and somatization; the
researchers noted gender differences, with more women exhibiting signs of depression and subsequent
drug abuse and more men exhibiting signs of somatization and subsequent drug abuse. The extant
literature also provides evidence of a relationship between women’s experiences of sexual assault and
NMPDU (McCauley, Amstadter, Danielson, Ruggiero, Kilpatrick, & Resnick, 2009) and increased risk of
NMPDU among adolescents with traumatic event histories (McCauley, et al., 2010).
Although information on the relationship between substance abuse (illicit drug use and NMPDU)
and trauma is available, information on the prevalence of trauma among drug court participants is scant
and information on drug court outcomes in regard to trauma exposure is non-existent. In a study of
lifetime trauma exposure and posttraumatic stress disorder in women sentenced to drug court by
Sartor, et al., (2012), the authors found that only 29 out of 319 (9%) women did not endorse any
traumatic events; 71% had trauma exposure without PTSD and 20% met criteria for PTSD. Although
female drug court participants were at a high risk for experiencing traumatic stress, correlations
between trauma exposure and other study variables were not accounted for and drug court outcomes
in relation to the study variables were not examined (Sartor, et al., 2012).
It is highly likely that a significant number of drug court participants have experienced trauma,
and this could impact drug court graduation rates. There is a need for research on the effects of trauma
on drug court graduation, as the extant literature is severely limited on this topic. The associations
among trauma, substance abuse, and related mental health symptoms are relevant to both the criminal
justice entities and treatment providers in that this relationship could negatively impact both criminal
recidivism and relapse rates. Research supports that PTSD mediates the adverse effects of trauma
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exposure among individuals with co-occurring disorders (Subica, Claypoole, & Wylie, 2012) and that the
combination of trauma history and trauma symptoms even without meeting criteria for a PTSD diagnosis
can influence addiction relapse (Tate, Brown, Unrod, & Ramo, 2004). Furthermore, research suggests
that integrated care that combines treatment for trauma-related symptoms and substance abuse can
not only decrease the likelihood of relapse, but also alleviate symptoms of suffering that contribute to
substance abuse (Brown, 2000, Cohen & Hien, 2006; Sacks et al, 2008). Incorporating trauma
assessment in drug court programs in conjunction with trauma-informed care when necessary could
provide answers to some of the whys and hows of effective drug court outcomes. Identifying traumatic
stress experiences as a correlate of substance abuse and determining if trauma predicts drug court
outcomes could facilitate a better understanding of both individual level characteristics that influence
drug court graduation and better explain the interaction effects found in the outcome literature.
Social Support, Substance Abuse, and Drug Courts
Although mental health problems and trauma may adversely affect drug court outcomes,
individuals with strong social supports may evidence more positive outcomes. Research on social
support has demonstrated the important role that positive social networks, access to personal support
systems, and perceptions of social support have in relation to both successful substance abuse
treatment and improvements in psychosocial functioning and motivation for recovery (Chao et al., 2013;
Chong & Lopez, 2005; Davis & Jason, 2005; Dobkin, De Civita, Paraherakis, & Gill, 2002; Ellis, Bernichon,
Yu, Roberts, & Harrell, 2004; Gainey, Peterson, Wells, Hawkins, & Catalano, 1995). House’s (1981)
sociological research on stress and social supports classified social support behaviors into four areas
including emotional support (love, caring, and empathy), instrumental support (tangible needs),
informational support (advice and information), and appraisal support (information for self-evaluation).
These different types of support can be provided to or for individuals through a variety of social or
interpersonal relationships, such as friends, family members, colleagues at work or school
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environments, or by community service providers. The functional aspect of social support can be
further divided into two domains: enacted or perceived support (Calysn, 2004). Enacted support
represents actual support received by an individual, whereas perceived support is the individual’s
perception of the availability of support, irrespective whether the person receives or accesses the
support (Calysn, 2004).
Research findings from studies on substance abuse treatment program outcomes demonstrate
that social support consistently predicts effective substance abuse treatment (Zerger, 2002) and
contributes to prolonged abstinence from substance abuse (Havassey, Wassserman, & Hall, 1995).
Dobkin, De Civita, Paraherakis, and Gill (2002) found higher dropout rates among individuals in
outpatient substance abuse treatment who reported low levels of social support. Additional research
has shown that substance abuse treatment clients who have positive social relationships are more likely
to successfully complete treatment (Watkins, Shaner, & Sullivan, 1999). Laudet, Cleland, Magura, Vogel,
and Knight (2004) report that social support for individuals in recovery is most important during the
beginning stages of treatment, because individuals may be struggling with abstinence and motivation
for change. A study by Warren, Stein, and Grella (2007) also supported this finding; results indicated
that the availability of social support when clients entered treatment predicted improvement in
substance abuse and mental health outcomes.
Additional research findings indicate that individuals with substance use disorders and low
social support had an increased risk for onset of mental illness, demonstrating a relationship between
social support and mental health symptoms (Pevalin & Goldberg, 2003). In a study of substance abuse
and co-occurring disorders among the homeless, Lam and Rosenheck (1999) found that perceived social
support was positively associated with substance abuse treatment and improved mental health
outcomes.
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There is a dearth of information on the role of social support and treatment outcomes for
individuals who misuse or abuse prescription medication; however, the few studies available on MAT for
opioid users offer conflicting findings. Smith and Rosen’s study (2009) of barriers to social support for
older methadone maintenance clients found that past traumatic experiences influenced a lack of trust
and self-isolation among clients which the authors concluded could affect abstinence during and after
treatment. Kidorf and colleagues (2005) studied a behavioral intervention within a hospital-based
medication-assisted treatment program where participants were encouraged to include non-drug using
family or friends in their treatment session. The authors found increased rates of abstinence among
those clients with access to social support. Finally, Wasserman, Stewart, and Delucchi (2001) found that
both structural and functional social support increased abstinence among opioid maintenance patients.
Social connectedness of drug court participants is less accounted for in the research, but the few
studies that have examined social interactions (isolation vs. connectedness) found conflicting results.
Rempel and DeStefano (2001) found that social isolation of drug court participants in terms of living
alone or in socially isolated neighborhoods was not significantly related to program outcomes, but that
predictors of general social connectedness, such as employment, being enrolled in school, or having a
stable living environment, were positively related to drug court completion. On the other hand, Hickert,
Boyle, and Tollefson (2009) found that living alone or in socially isolated neighborhoods had negative
impacts on drug court graduation and that drug court participants who spent more time with family
were more likely to graduate from drug court treatment than participants who did not spend time with
family. Correspondingly, Hiller, Knight, and Simpson (1999) found that although drug court participants
were socially connected, their deviant peer networks predicted failure to graduate from drug court.
Investigation of the association between social support and treatment outcomes for NMPDU clients is
necessary, given the complex relationship between mental health symptoms and substance abuse and
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evidence that suggests isolation and loneliness caused by these symptoms could negatively impact
successful treatment outcomes.
Research on the association among trauma, mental health problems, substance abuse, and
social support demonstrates similar findings in regard to lower levels of social support being associated
with negative outcomes and higher levels of social support being related to positive outcomes for both
psychosocial functioning and treatment recovery (Ashley, Marsden, & Brady, 2003; El-bassel, et al.,
1996). Individuals who have experienced trauma and perceive themselves as having less access to
positive social support are more likely to engage in negative coping mechanisms such as substance
abuse and are more likely to develop mental health symptoms in relation to their trauma experiences
(Cook, et al., 2005; Knight, Logan, & Simpson, 2001). Furthermore, women with trauma and substance
abuse histories are more likely to experience negative social and criminal justice outcomes than men in
these situations; women with trauma and substance abuse are more likely to live in poverty, be single
parents, be at risk for losing custody of their children, and be more likely to engage in criminal activities
such as prostitution (Cohen & Hein, 2006; Ehrmin, 2001; Najavits, et al., 1997). These findings
emphasize the importance of assessing psychosocial factors such as trauma, mental health symptoms,
and access to prosocial supports in order to tailor treatment needs to provide the most benefit for the
client as well as society. By examining these psychosocial influences within a drug court context, further
information can be gained on factors that influence drug court graduation.
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Chapter 4: Research Design and Methods
There is an established research literature on positive findings of alternatives to sentencing
programs (Anglin, Douglas, Longshore, & Turner, 1999; Clear & Schrantz, 2011; Miller, 2004), particularly
drug court outcomes (Gallagher, 2013; Mitchell, Wilson, Eggers, MacKenzie, 2012; Rempel, Green, &
Kralstein, 2012). However, gaps remain in our knowledge of certain factors that influence drug court
program success or the lack thereof. In particular, although it is established that involvement in drug
court programs increases the likelihood of positive outcomes for justice-involved substance abusers,
research demonstrates that these outcomes are not universal and that for some, drug court programs
do not work. Questions remain regarding for whom drug courts work. Given the significant social
impact and vast criminal justice burden related to substance abusing offenders, a more comprehensive
determination of participant characteristics that affect successful drug court completion should be
considered. Research demonstrates a significant relationship between negative psychosocial factors
such as trauma, mental illness, and substance use (Asberg & Renk, 2012; Belenko, 2006; Kingston &
Raghavan, 2009; Lesperance, Moore, Barret, Young, Clark and Ochshorn, 2011; Picken & Tarrier, 2011;
Rosenberg, 2011; Stover, MacMahon, & Easton, 2012). Additionally, the literature demonstrates a
relationship between positive psychosocial factors and recovery, such as prosocial support systems
(Havassy, Hall & Wasserman, 1991; Maguire, 2001; Norris, 2009; Spjeldnes, Jung, Maguire, & Yamatani,
2012). The literature on co-occurring disorders and trauma-informed care emphasizes the need for
simultaneous treatment for both mental health or trauma-related symptoms and substance use in order
to decrease the likelihood of substance abuse relapses and criminal justice recidivism while providing a
therapeutic response to the effects of mental illness and/or trauma (Abbott, 2003; Amaro, Chernof,
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Brown, Arevalo, & Gatz, 2007; Dass-Brailsford & Myrick, 2010; Minkoff, 2008; Najavits, Weiss, & Shaw,
1999; Najavits, 2004). This exploratory study utilizes secondary data to examine the demographic and
psychosocial factors associated with drug court graduation among a medication-assisted treatment
population. Using a variety of measures to assess trauma experiences, mental health symptom severity,
and prosocial support in relation to drug court graduation affords a more comprehensive approach to
understanding the impact of drug court while accounting for psychosocial factors that may influence
substance abuse treatment. Furthermore, research on medication-assisted treatment populations is
limited and more information is needed. Studying demographic and psychosocial factors facilitates a
further exploration of the question, for whom are drug courts beneficial? The results of this study
contribute to the literature on psychosocial factors and their impact on drug court outcomes.
Procedures
The data for this study come from a pre-existing de-identified data set from an evaluation of a
medication-assisted drug court treatment program. The Hillsborough County Medication-assisted Drug
Court Treatment Program (MADCT) and the external evaluation component were funded through a
federal grant by the Substance Abuse and Mental Health Services Administration – Center for Substance
Abuse Treatment (SAMHSA-CSAT). The purpose of the MADCT program was to offer offenders with
opiate addiction a harm-reduction based outpatient treatment option as an alternative to abstinencebased programs or jail/prison – with the ultimate goal of supporting clients in their efforts to achieve
sobriety and stability. Successful treatment completion and compliance with drug court requirements
allow first-time drug offenders the opportunity to avoid having a felony conviction upon completion of
the program. Secondary data were utilized to assess the effects of psychosocial factors (traumatic stress
experiences, mental health symptom severity, and social support) on drug court graduation. It was
hypothesized that individuals with higher instances of traumatic stress experiences and more severe
mental health symptoms would have less favorable drug court outcomes in terms of successful
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graduation, whereas individuals with access to prosocial support systems would have more favorable
drug court outcomes in terms of successful graduation.
Data were collected from individuals who were enrolled in a medication-assisted drug court and
attending court-ordered substance abuse treatment. Prior to data collection, approval from the
University of South Florida Institutional Review Board (IRB) was obtained, and all study personnel
completed instruction in human subjects research. Each participant gave informed consent to
participate in the evaluation study from which data for this study were used. A modification to the IRB
was approved to allow for further analyses using these data to inform this dissertation.
Sample
The sample for this study was composed of participants in the Hillsborough County Medicationassisted Drug Court Treatment (MADCT) Program of the 13th Judicial Circuit, Hillsborough County,
Florida. All participants in this program had histories of drug abuse and were opiate users. Drug abuse
is characterized by a maladaptive pattern of substance use to the point where the individual experiences
significant cognitive and behavioral impairment or emotional distress that has an impact on work,
school, or the home (APA, 2000; DSM-IV). Eligibility criteria for the MADCT program included male and
female offenders who had: (1) prescription drug-related charges, (2) no history of violent criminal
offenses, (3) no diagnosis of severe mental illness, (4) no alleged sexual perpetration, and (5) willingness
to participate in medication-assisted drug court treatment. Program participation was voluntary. The
MADCT program provided approximately six months of outpatient treatment to individuals who abused
or misused prescription opiates. The treatment utilized an evidence-based treatment protocol, the
Matrix model, in conjunction with medication-assistance. The Matrix Model utilizes cognitivebehavioral concepts to reinforce positive behavioral changes (Rawson, et. al, 1995 & 2002). MADCT
treatment emphasized individual contact with a substance abuse counselor, education about drug
abuse, relapse prevention, social support, twelve-step participation, and issues critical to addiction and
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relapse. Participants received medication management in the form of methadone or suboxone as part
of their substance abuse treatment and were required to attend the clinic daily in order to obtain their
medication. All MADCT clients participated in individual and group counseling sessions, weekly
attendance at a self-help group meeting, such as Alcoholics Anonymous/Narcotics
Anonymous/Methadone Anonymous, one to two random drug screens per week, and monthly judicial
reviews. Although most participants completed the treatment component of drug court within six
months, the majority remained in drug court for judicial reviews and drug testing up to one year or until
they satisfied all of the requirements of the drug court program. Upon successful graduation from the
MADCT program, participants’ charges were dropped and they were allowed to petition the court to
have their records expunged. Individuals who did not satisfy the requirements of the MADCT program
were sentenced for their original charges and served jail time. Some participants did not successfully
graduate due to absconding from treatment (these had active warrants or were jailed), were
incarcerated for charges not related to the charge that led them into the MADCT program, were
transferred to a different jurisdiction for criminal justice reasons, or were involuntarily discharged from
treatment due to non-compliance.
The sample for the current study was drawn from the population of all individuals who were
participants in the MADCT program between January, 2010 and April, 2012. To have their data included
in the analysis, participants must have completed all study measures and must have been discharged
from the program and their graduation or non-graduation status recorded. Only 108 of the original 145
participants had completed all study measures. Of these 108 who had completed all study measures, 90
had been discharged from the program and were thus eligible for inclusion in the analysis. To ensure the
representativeness of the sample, analyses were performed to examine potential demographic
differences among the entire drug court population (N= 145), the included sample (n=90), and the
excluded sample (n=55, those still active in the drug court program and/or declined to complete all
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study measures). No statistically significant differences emerged among any of these groups (see Table
4). In the absence of any significant differences, analyses were restricted to the final sample that were
no longer active in drug court and had completed all study measures (N=90).

Covariates

Table 4. Comparison of Total Population, Excluded, and Final Sample Demographics
Total
Excluded
Final
Population
Sample
Sample
(N = 145)
(N = 55)
(N = 90)
Significance
Mean SD or Mean SD or Mean SD or
or N
%
or N
%
or N
%
Age
28.15
7.89
28.4
8.36
28.0
7.64
t(143) = -0.338, p = .736
Gender
Female
79
54.5%
35
63.6%
44
48.9%
Male
66
45.5%
20
36.4%
46
51.1%
X2(1) = 1.088, p = .297
Education
LT High
43
29.7%
21
38.2%
22
24.4%
School
43
29.7%
18
32.7%
25
27.8%
High School
59
40.7%
16
29.1%
43
47.8%
X2(2) = 5.384, p = .068
GT High
School
Employment
Unemployed
94
64.8%
38
70.4%
56
62.2%
Employed
50
34.5%
16
29.6%
34
37.8%
X2(1) = 0.989, p = .320

In the final sample used for the present study, there were 44 women (48.9%) and 46 men
(51.1%). Participants ranged in age from 18-59 (X = 28.15, SD = 7.89). As depicted in Table 4, 22
participants reported their level of education as less than high school (24.4%), 25 reported earning a
high school diploma or equivalent GED (27.8%), and 43 participants reported completing some college
or more (47.8%). The majority of participants were unemployed at baseline (62.2%).
Research Questions
In order to address the impact of psychosocial factors on drug court graduation, four questions were
examined:


What are the demographic correlates of drug court graduation?
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What is the relationship between individuals’ experiences of traumatic stress and drug court
graduation?



What is the relationship between mental health symptom severity and drug court graduation?



What is the relationship between prosocial support systems and drug court graduation?

Results of the study inform a discussion of whether demographic and psychosocial factors should be
considered in alternatives to sentencing programs for justice-involved individuals with substance abuse.
Measures of Variables
Demographics – For the purposes of this study, demographics include the following variables:
age (in years), gender (female = 1, male = 0), level of education (measured as less than high school =1,
high school or GED equivalent = 2, or some college or college graduate = 3), and employment (measured
as employed = 1 or unemployed = 2). These variables were chosen as covariates because extant
empirical research has identified these as being predictors of drug court outcomes.
Drug Court Graduation - Participants’ drug court graduation status was coded as yes (successful
graduation = 1; N = 68) or no (did not graduate = 0; N = 22); this information was provided by the court.
MADCT participants are recorded as “graduates” when they complete treatment and satisfy all drug
court requirements including regular judicial reviews and drug testing beyond treatment completion.
MADCT participants are recorded as “non-graduates” when they fail to meet drug court requirements
(completing treatment, attending judicial reviews, no further criminal justice involvement).
Traumatic Stress - Traumatic stress experiences were measured using the Traumatic Stress Scale
(TSS), part of the Global Appraisal of Individual Needs (GAIN) instrument (Dennis, White, Titus, &
Unsicker, 2006). The Traumatic Stress Scale encompasses a range of exposure(s) to trauma over the
lifetime as either a victim or a witness to victimization. The TSS is a 13-item measure of past year
symptoms or memories related to past trauma (e.g., post-traumatic stress disorder PTSD), current
trauma (e.g., acute stress disorder (ASD) or other disorders of extreme stress (DES or complex PTSD; e.g.
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related to on-going childhood maltreatment, battering victims, domestic violence or sexual abuse
survivors) associated with exposure to traumatic events. Some examples of items on the TSS are: When
something reminds you of the past, you become very distressed and upset; you had nightmares about
things in your past that really happened; you felt guilty about things that happened because you felt like
you could have done something to prevent them? Scores are the sum of ‘‘yes’’ responses, with higher
scores indicating more problems related to memories of traumatic events. Scores range from 0-13 and
the authors provide guidelines for interpretation based on prior research determining demographic
norms (Modisette, Hunter, Ives, Funk, & Dennis, 2009): scores are interpreted as no (0 symptoms
endorsed), moderate (1–4 symptoms endorsed), and high (5–13 symptoms endorsed). The TSS is based
on the Civilian Mississippi Scale for PTSD (Hyer, Davis, et al., 1991; Keane, Caddell, & Taylor, 1988; King,
King, et al., 1993; Kulka, Schlenger, et al., 1991; Lauterbach, Vrana, et al., 1997; Vreven, Gudanowski, et
al., 1995). For the present study, the Cronbach’s alpha coefficient of reliability is α= .934.
Mental Health Symptom Severity – Mental health symptom severity was measured using the
Global Severity Index (GSI), which is based on the Brief Symptom Inventory (BSI; Derogatis, 1982). The
BSI is a 53-item measure that assesses common psychological symptoms. The Brief Symptom Inventory
is an abbreviated version of the Symptom Checklist-90 (SCL-90). Some examples of items on this
measure are: During the past seven days, including today, how much were you distressed by feeling
suddenly scared for no reason; feeling tensed or keyed up; feeling nervous when you are left alone?
Respondents indicate the extent to which each of the 53 problems on the checklist has caused distress
over the past 7 days. The BSI uses a 5-point Likert response scale, ranging from (0) not at all to (4)
extremely for each item. The measure evaluates nine primary symptom dimensions: depression,
interpersonal sensitivity, anxiety, phobic anxiety, paranoid ideation, somatization, obsessive-compulsive,
hostility, and psychoticism. The BSI provides a score of overall mental health functioning called the
Global Severity Index (GSI), which provides information on the number of symptoms and intensity of
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perceived distress of the individual using the mean of the nine subscale scores. The GSI score was used
for analyses in this study. Research indicates it is a useful measure of psychological functioning exhibited
during inpatient and outpatient treatment for both males and females (Allen, Coyne, & Huntoon, 1998).
For this study, the Cronbach’s alpha coefficient of reliability is α= .956.
Social Support - Social support was measured using the Social Support Survey Instrument (SSSI;
Sherbourne & Stewart, 1991). The SSSI is an 18-item brief, multidimensional, self-report survey of social
support. The SSSI consists of four separate subscales: emotional, tangible, affectionate, and positive
social interaction. The emotional subscale consists of eight items that relate to guidance and appraisal.
The tangible support subscale consists of four items that relate to material support, aid, and reliable
alliance. The affectionate subscale consists of three items that relate to attachment and affect. The
positive social interaction subscale consists of four items that relate to social integration, belonging, and
social companionship. Some examples of items on this measure are: How often is each of the following
kinds of support available to you – someone you can count on to listen to you when you need to talk
(emotional subscale); someone to take you to the doctor if you needed it (tangible subscale) someone
who shows you love and affection (affectionate subscale); someone to do something enjoyable with
(positive social interaction subscale)? The SSSI also provides a measure of overall social support using a
mean score for all 18 items. The overall social support score will be used for analyses in this study.
Respondents indicate how often each of the 18 types of support is available to them. The SSSI uses a 5point Likert response scale, ranging from (0) none of the time to (4) all of the time for each item. For this
study, the Cronbach’s alpha coefficient of reliability is α= .967.
Analytic Plan
This study attempted to determine whether three independent variables related to psychosocial
functioning (traumatic stress experiences, mental health symptom severity, and prosocial support) had
an effect on drug court graduation (completion or non-completion), when demographic characteristics
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(age, gender, level of education, and employment) were held constant. Logistic regression was
considered the preferred statistical technique for this type of outcome-based dependent variable, as
this method regresses a binary (dichotomous) dependent variable on an independent variable or set of
variables to produce an estimate of the odds, or “the relative probability of falling into one of two
categories” (Menard, 1995, p.12). Studies using logistic regression commonly begin analyses with
bivariate correlations to determine which variables contribute to model fit. Hosmer and Lemeshow
(2010) presented this method as an adequate technique for analyses involving a binary outcome
because eliminating unproductive variables increases overall model fit. Logistic regression models using
a forward stepwise method will be utilized to answer hypotheses related to the links between
psychosocial factors and drug court graduation. The use of stepwise methods is debated in the
literature (see Hosmer & Lemeshow, 1989; Mundry & Nunn, 2009), but is deemed acceptable when the
purpose of the research is the identification of predictors (Hosmer & Lemeshow, 1989; Menard, 2010).
All statistical analyses in this study will be conducted using SPSS version 20 for Windows (SPSS, 2012).
All statistical tests will be two-tailed, with statistical significance determined based upon an alpha level
of 0.05. Even though the hypotheses are not multidirectional, it would be overly confident to assume
that the hypotheses are correct and it must be considered that the direction could be the opposite. By
using two-tailed tests, the probability is calculated from both tails and the possibility of missing an effect
in the other direction is eliminated (BMJ, 1994; Hillenmeyer, 2006; UCLA, 2009).
Research Question 1
Logistic regression was utilized to assess first if there was a relationship between demographic
variables (age, gender, level of education, and employment status) and drug court graduation (program
completion vs. non-completion). Each of the four demographic variables was entered as steps of the
regression to determine whether demographics contribute to the prediction of drug court graduation.
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Research Question 2
Logistic regression was utilized to assess next if there was a relationship between traumatic
stress and drug court graduation (program completion vs. non-completion) while controlling for
demographic variables (age, gender, level of education, and employment status). The demographic
variables were entered as covariates into the first step of the regression. The predictor variable
(traumatic stress) was entered into the second step of the regression along with the demographic
variables to determine whether traumatic stress contributes to the prediction of drug court graduation
over and above what demographic covariates account for.
Research Question 3
Logistic regression was utilized to assess whether there was a relationship between mental
health symptom severity and drug court graduation (program completion vs. non-completion) while
controlling for demographic variables (age, gender, level of education, and employment status). The
demographic variables were entered as covariates into the first step of the regression. The predictor
variable (mental health symptom severity) was entered into the second step of the regression along
with the demographic variables.
Research Question 4
Logistic regression was utilized to assess finally whether there was a relationship between
prosocial support and drug court graduation (program completion vs. non-completion) while controlling
for demographic variables (age, gender, level of education, and employment status). The demographic
variables were entered as covariates into the first step of the regression. The predictor variable
(prosocial support) was entered into the second step of the regression along with the demographic
variables.
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Chapter 5: Results
The purpose of this study was to examine the relationships between demographic
characteristics and psychosocial factors of drug court participants and successful or unsuccessful drug
court graduation. First, bivariate analyses were conducted to determine the relationships among all of
the variables included in the study. Logistic regression was then conducted to examine the effects of
the demographic covariates and independent variables on the dependent variable of drug court
graduation.
Bivariate Analyses
Table 5 presents descriptive information for the sample according to drug court graduation
status. T-tests and Chi-squares were calculated to determine differences between the group that
graduated and the group that did not graduate from the drug court program. Although participants in
this study demonstrated no marked differences across categories of age and employment according to
drug court graduation status (completed vs. did not complete), there was a statistically significant
difference in regard to level of education. As depicted in Table 5, for participants who graduated drug
court, the majority had completed at least some college (55.9%) by the time of the study. In contrast,
among those participants who did not graduate from drug court 45.5% reported less than high school as
their highest level of education and only 22.7% reported some college or more. Differences between
graduates and non-graduates on scale scores of the independent variables assessing mental health
symptom severity, social support, and traumatic stress were not statistically significant. However,
differences in scores on social support, particularly the subscale of affectionate support, and traumatic
stress were approaching significance. The small size of the sample may have some bearing on this, in
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that a larger sample size may have produced statistically significant results at the .05 level; future
research should attempt to examine these questions with a larger sample size. The descriptive statistics
produced an interesting finding in terms of gender with female drug court clients being unsuccessful in
terms of drug court graduation in only eight out of forty four cases (9%) compared to male drug court
clients who were not successful in fourteen out of forty six cases (31%).

IV

Covariates

Table 5. Descriptive Statistics for Selected Sample by Drug Court Graduation
Total Sample
Graduated
Did Not Graduate
(N=90)
(N = 68)
(N = 22)
Mean SD or %
Mean
SD or %
or N
or N
Age
28.56
8.367
26.18
4.404
Gender
Female
36
53%
8
36%
Male
32
47%
14
64%
Education
LT HS
HS
GT HS
Employment
Unemployed
Employed
Brief Symptom Inventory
– Global Scale Index (IV)
Social Support Survey
Instrument - Overall (IV)
Social Support Survey
Instrument – Emotional
Support Subscale(IV)
Social Support Survey
Instrument – Tangible
Support Subscale(IV)
Social Support Survey
Instrument –
Affectionate Support
Subscale(IV)
Social Support Survey
Instrument – Positive
Social Interaction
Subscale (IV)
TSS (IV)
*p <.05

Significance

t(88) =1.273, p = .206
X2(1) = 1.828, p = .176

X2(2) = 9.254, p = .010*
12
18
38

17.6%
26.5%
55.9%

10
7
5

45.5%
31.8%
22.7%
X2(1) = 0. 025, p = .875

42
26
0.73

61.8%
38.2%
0.53

14
8
0.74

63.6%
36.4%
0.60

X2(88) = -.071, p = .944

3.87

0.90

3.44

1.09

X2(88) = 1.841, p = .069

3.76

.98

3.30

1.11

X2(88) = 1.852, p = .067

3.92

1.12

3.70

1.26

X2(88) = .809, p = .421

4.12

1.03

3.60

1.31

X2(88) = 1.945, p = .055

3.82

1.12

3.32

1.21

X2(88) = 1.803, p = .075

4.16

4.33

2.27

3.99

X2(88) = 1.813, p = .073†
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In addition to examining the relationships between graduation status and each demographic
and psychosocial variable, correlation coefficients were calculated to examine the relationships among
all the demographic covariates, independent variables, and dependent variable in this study. Bivariate
correlations shown in Table 6 indicated positive correlations between gender and two of the three other
demographic covariates (education and employment) and one of the three independent variables
(mental health symptom severity). Female drug court participants were more likely to have higher levels
of education (r = .210, p < .05) and to be employed (r = .441, p < .01) than male drug court participants.
Higher scores on the BSI, which are indicative of higher mental health symptom severity (r = .288, p <.
05), were associated with MADCT participants who were female. Results indicated a negative
correlation between social support and mental health symptom severity (r = -.224, p <. 05). Further
analysis shows that mental health symptom severity is negatively correlated with the subscales of
tangible support (r = -.230, p < .05) and positive interaction (r = -.232, p < .05). The only variable
associated with drug court graduation was education; results indicate that those with higher levels of
education were more likely to successfully graduate from drug court (r = .321, p < .01). Although none
of the bivariate results produced significant findings in terms of the impact of the independent variables
on drug court graduation, multivariate analyses were conducted for these complex research questions
to determine if further or possibly contradictory results were found. Researchers have indicated that
discrepancies among univariate, bivariate, and multivariate statistics where a variable is not significant
in the first set of analyses, but becomes significant in the next can be accounted for by: effects of
unbalanced sample size, missing data influences, considerable within-group variation compared to
between-group variation, and the presence of interaction (Lo, Li, Tsou, & See, 1995).
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Table 6. Bivariate Correlations Study Variables
Variables

1

2

3

4

5

6

7a

7b

7c

7d

7e

1. Age

Independent Variables

Demo

2. Gender

.137

(Female)
3. Education

.137

.210*

4. Employment

.164

.441**

-.114

5. Mental Health
Symptom Severity
(GSI/BSI)

.072

.288**

-.013

.319**

6. Traumatic Stress
Experiences (TSS)

.126

.141

.020

.160

.141

7a. Social Support

-.120

-.059

-.011

-.053

-.224*

-.080

b. Emotional

-.063

-.025

.018

-.038

-.181

-.128

.907**

-.262*

-.075

-.026

-.016

-.230*

-.088

.824**

.596**

-.056

-.023

-.005

-.111

-.183

-.017

.904**

.727**

.748**

-.072

-.106

-.028

-.077

-.232*

.025

.862**

.666**

.663**

.815**

.134

.143

.321**

-.017

-.008

.190

.193

.194

.086

.203

Subscale
c. Tangible
Subscale
d. Affectionate
Subscale
e. Positive

DV

Subscale
8. Graduation

.189

*p <.05 ** p < .01
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Multivariate Analyses
Research Question 1
Logistic regression was conducted to assess if there was a relationship between demographic
variables (age, gender, level of education with “greater than high school” as the reference category, and
employment status) and drug court graduation (program completion vs. non-completion). When all
four demographic variables were used to predict graduation (see Table 7), only education remained a
significant predictor, net of all other factors. Specifically, the exp (b) of .190 indicates that those with
more than a high school education (the reference category) are 1.000/0.190 = 5.26 times more likely
than those with less than a high school education to graduate from drug court. Those with a high school
education only were not significantly different from those with more than a high school education in
their graduation rate, after controlling for age, gender, and employment. Further, neither age nor
gender nor employment significantly influenced the probability of graduation from drug court. Together,
these demographic covariates account for about 16.8% of the variance in the probability of drug court
graduation. Despite education being the only significant demographic predictor of drug court
graduation, all demographic variables will be controlled for in each regression model to reduce any
effects of variation for each research question.
Table 7. Logistic regression analysis testing the effect of demographic variables on drug court graduation
Independent Variable
B
SE
p
Wald
df
Exp (B)
Age
.036
.039
.358
.846
1
1.037
Gender (male)
-.478
.612
.435
.609
1
.620
Education: Less than High
-1.660
.670
.013*
6.130
1
.190
School (versus More than HS)
Education: High School Only
-.955
.663
.149
2.078
1
.385
(versus More than HS)
Employment (employed)
.207
.627
.742
.808
1
1.230
2
*p <.05; R =.168
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Research Question 2
A logistic regression analysis was conducted next to test the hypothesis that drug court clients
with higher levels of traumatic stress experiences would have less successful drug court outcomes in
terms of graduation. Demographics were controlled for by entering the covariates in Step 1 of the
logistic regression. The independent variable, traumatic stress, was entered in Step 2. The Hosmer and
Lemeshow test of model fit showed a good model fit X2 (8) = 6.382, p = .605. As Table 8 demonstrates,
the results of the final model (Wald = 2.907, p=.088) suggest that higher levels of traumatic stress
experiences did not affect drug court graduation. Nagelkerke’s R square showed that traumatic stress
combined with demographics accounted for 21.4% of the total variance as compared to 16.8% in step 1
with only the demographic covariates entered.
Table 8. Logistic regression analysis testing the effect of traumatic stress on drug court graduation
controlling for demographics (using TSS as measure of trauma)
Independent Variable
B
SE
p
Wald
df
Exp (B)
Age
.031
.039
.423
.643
1
1.031
Gender (male)
-.516
.620
.406
.692
1
.597
Education: Less than High
-1.722
.677
.011*
6.474
1
.179
School (versus More than HS)
Education: High School Only
-1.010
.670
.132
2.271
1
.364
(versus More than HS)
Employment (employed)
.340
.641
.596
.692
1
.405
Traumatic Stress Scale
.114
.067
.088
2.907
1
1.121
2

*p <.05 : R = .214

Considering that perhaps this null result was due to the manner in which the TSS is scored, the
variable was recoded from a continuous variable to a categorical variable based on the cut off scores
provided by the authors of the measure that indicate low/no, moderate, or high traumatic stress
experience. Figure 1 illustrates that the variables are not normally distributed regardless of how the
variable is measured; logistic regression does not require the variables to be normally distributed, just
the error terms (Burns & Burns, 2008). Logistic regression was run again (see Table 9) with the re-coded
variable. Although the Hosmer and Lemeshow test of model fit showed a good model fit X2 (8) = 7.143, p
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= .521, the influence of this alternative measure of traumatic stress on drug court graduation after
controlling for demographics was not statistically significant. Nagelkerke’s R square showed that this
measure of traumatic stress combined with demographics accounted for 22% of the total variance in the
probability of drug court graduation.
A further consideration as to why the effect of traumatic stress on graduation was not
significant was that perhaps the measure of trauma, which relied on memories of past events, was too
far removed in time from graduation status. Participants in the study also completed the Posttraumatic
Stress Disorder Checklist- Civilian Version at baseline (PCL), which consists of 17 items that indicate how
much distress a trauma symptom has caused in the past 30 days. For this study, the Cronbach’s alpha
score for the PCL measure was α =.91. An additional logistic regression analysis (see Table 10) was
conducted to test the hypothesis that drug court clients with higher levels of traumatic stress
experiences would have less successful drug court outcomes in terms of graduation. Demographics
were controlled for by entering the covariates in Step 1 of the logistic regression. The independent
variable, traumatic stress as measured by the PCL, was entered in Step 2. The Hosmer and Lemeshow
test of model fit showed a good model fit X2 (8) = 3.846, p = .871. The results again suggested that
higher traumatic stress experiences, as measured by the PCL, did not have an influence on successful
drug court graduation. Nagelkerke’s R square showed that the model including demographics and the
PCL measure accounted for only 18% of the total variance in drug court graduation.
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Figure 1. Comparison of Distribution of Trauma Scores
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Table 9. Logistic regression analysis testing the effect of traumatic stress on drug court graduation
controlling for demographics (using TSS Revised as measure of trauma)
Independent Variable
B
SE
p
Wald
df
Exp (B)
Age
.027
.039
.485
.487
1
1.028
Gender (male)
-.459
.619
.458
.550
1
.632
Education: Less than High
-1.655
.676
.014*
5.999
1
.191
School (versus More than HS)
Education: High School Only
-1.004
.672
.135
2.230
1
.366
(versus More than HS)
Employment (employed)
.364
.640
.570
.322
1
1.438
Traumatic Stress Scale
.573
.315
.069
3.301
1
1.773
Revised
*p <.05; R2=.220

Table 10. Logistic regression analysis testing the effect of traumatic stress on drug court graduation
controlling for demographics (using PCL as measure of trauma)
Independent Variable
B
SE
p
Wald
df
Exp (B)
Age
.032
.039
.414
.667
1
1.033
Gender (male)
-.636
.650
.328
.956
1
.529
Education: Less than High
-1.680
.674
.013*
6.221
1
.186
School (versus More than HS)
Education: High School Only
-.979
.666
.141
2.166
1
.376
(versus More than HS)
Employment (employed)
.061
.655
.926
.009
1
1.063
Posttraumatic Stress Checklist
-.022
.025
.372
.795
1
.978
*p <.05; R2=..180

Research Question 3
A logistic regression analysis was conducted next to test the hypothesis that drug court clients
with higher levels of mental health symptom severity would have less successful drug court outcomes in
terms of graduation. Demographics were controlled for by entering the covariates in Step 1 of the
analysis. The independent variable, mental health symptom severity, was entered in Step 2. The
Hosmer and Lemeshow test of model fit showed a good model fit X2 (8) = 4.965, p = .761. As Table 11
demonstrates, the results of the final model (Wald = .075, p=.784) suggest that higher levels of mental
health symptom severity did not affect drug court graduation. Nagelkerke’s R square showed that
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mental health symptom severity combined with demographics accounted for 16.9% of the total variance
as compared to 16.8% in step 1 with only the demographic covariates entered.
Table 11. Logistic regression analysis testing the effect of mental health symptom severity on drug court
graduation controlling for demographics
Independent Variable
B
SE
p
Wald
df
Exp (B)
Age
.036
.039
.355
.856
1
1.037
Gender (male)
-.519
.633
.412
.672
1
.595
Education: Less than High
.671
.014*
6.054
1
.192
School (versus More than HS)
1.651
Education: High School Only
-.964
.664
.146
2.110
1
.381
(versus More than HS)
Employment (employed)
.182
.635
.775
.082
1
1.199
Mental Health Symptom
-.147
.536
.784
.075
1
3.561
Severity
*p <.05; R2= .169
Research Question 4
A logistic regression analysis was conducted next to test the hypothesis that drug court clients
with higher levels of access to prosocial support would have more successful drug court outcomes in
terms of graduation. Demographics were controlled for by entering the covariates in Step 1 of the
logistic regression. The independent variable, access to prosocial support systems (Overall Social
Support), was entered in Step 2. The Hosmer and Lemeshow test of model fit showed a good model fit
X2 (8) = 4.965, p = .761. As Table 12 demonstrates, the results of the final model (Wald = .378, p=.036)
suggest that higher levels of access to prosocial support systems did have a relationship with drug court
graduation. Nagelkerke’s R square showed that this variable accounted for 23.4% of the total variance
as compared to 16.8% in step 1 with only the demographic covariates entered. The results indicate
some support for the notion that individuals with higher levels of access to prosocial support systems
are more likely to successfully graduate from drug court.
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Table 12. Logistic regression analysis testing the effect of access to prosocial support on drug court
graduation controlling for demographics
Independent Variable
B
SE
p
Wald
df
Exp (B)
Age
.044
.039
.261
1.262
1
1.045
Gender (male)
-.657
.643
.307
1.044
1
.519
Education: Less than High
-1.984
.696
.016*
5.847
1
.186
School (versus More than
HS)Education: More than
High School versus Less than
High School
Education: High School Only
-1.203
.697
.084
2.979
1
.300
(versus More than HS)
Employment (employed)
.286
.653
.661
.192
1
1.331
Overall Social Support
.607
.290
.036*
4.378
1
1.835
*p <.05; R2=.234
To further explore the relationship between prosocial support and drug court graduation,
additional analyses were conducted using the separate scales of the Social Support Survey Instrument to
determine which type of support had the greatest influence on drug court graduation. In separate
models, the overall scale was replaced by adding in each subscale. Table 13 shows the results of logistic
regression analysis using the emotional support subscale of the Social Support Survey Instrument in the
second step of the model; the demographic covariates were entered in the first step. The Hosmer and
Lemeshow test of model fit showed a good model fit for the overall model X2 (8) = 8.725, p = .366. The
results of the final model using the first subscale, Emotional Support (Wald 3.834, p = .050), suggest that
higher levels of access to emotional support was moderately related to successful drug court
graduation, net of the effects of demographic characteristics. Nagelkerke’s R square showed that this
variable, along with the demographic variables, accounted for 22.5% of the total variance as compared
to 16.8% in step 1 with only the demographic covariates entered.
An additional logistic regression was conducted for the second subscale of the SSSI. As Table 14
demonstrates, the Tangible Support subscale of the SSSI was not a significant predictor of drug court
graduation (Wald 1.703, p = .192) when demographic variables were controlled. Nagelkerke’s R square
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showed that this model accounted for 19.3% of the total variance as compared to 16.8% in step 1 with
only the demographic covariates entered.
Table 15 shows the results of logistic regression analysis using the Affectionate Support subscale
of the SSSI. The results of the final model using this scale (Wald.158, p = .041) suggest that higher levels
of access to affectionate support was related to successful drug court graduation, controlling for
demographic variables. Nagelkerke’s R square showed that this model accounted for 23.1% of the total
variance as compared to 16.8% in step 1 with only the demographic covariates entered.
A final logistic regression was conducted with the last subscale of the SSSI, Positive Social
Interaction. As Table 16 demonstrates, the results of the final model (Wald = 4.413, p = .036), suggest
that higher levels of access to positive social interaction is related to successful drug court graduation,
controlling for demographics. Nagelkerke’s R square showed that this variable, along with the
demographic variables, accounted for 23.5% of the total variance as compared to 16.8% in step 1 of the
model with only the demographic covariates entered.
Table 13. Logistic regression analysis testing the effect of the emotional support subscale of the Social
Support Survey Instrument on drug court graduation controlling for demographics
Independent Variable
B
SE
p
Wald
df
Exp (B)
Age
.039
.039
.318
.995
1
1.040
Gender (male)
-.601
.628
.339
.913
1
.549
Education: Less than High
-1.663
.693
.016*
5.760
1
.190
School (versus More than HS)
Education: High School Only
-1.164
.697
.095
2.791
1
.312
(versus More than HS)
Employment (employed)
.262
.641
.683
.167
1
1.300
Emotional Support Subscale
.527
.269
.050*
3.384
1
1.694
*p <.05; R2=.225
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Table 14. Logistic regression analysis testing the effect of the tangible support subscale of the Social
Support Survey Instrument on drug court graduation controlling for demographics
Independent Variable
B
SE
p
Wald
df
Exp (B)
Age
.048
.040
.228
1.450
1
1.09
Gender (male)
-.592
.630
.347
.883
1
.553
Education: Less than High
.677
.015*
5.987
1
.193
School (versus More than HS)
1.643
Education: High School Only
.676
.120
5.888
1
.349
(versus More than HS)
1.052
Employment (employed)
.304
.643
.637
2.423
1
1.355
Tangible Support Subscale
.313
.240
.192
1.703
1
1.368
*p <.05; R2=.193
Table 15. Logistic regression analysis testing the effect of the affectionate support subscale of the Social
Support Survey Instrument on drug court graduation controlling for demographics
Independent Variable
B
SE
p
Wald
df
Exp (B)
Age
.040
.040
.313
1.019
1
1.041
Gender (male)
-.513
.635
.420
.651
1
.599
Education: Less than High
.700
.013*
6.131
1
.177
School (versus More than HS)
1.734
Education: High School Only
.696
.077
3.120
1
.293
(versus More than HS)
1.229
Employment (employed)
.137
.653
.834
.044
1
1.147
Affectionate Support Subscale
.493
.242
.041*
4.158
1
1.637
2
*p <.05; R =.231
Table 16. Logistic regression analysis testing the effect of the positive social interaction subscale of the
Social Support Survey Instrument on drug court graduation controlling for demographics
Independent Variable
B
SE
p
Wald
df
Exp (B)
Age
.042 .041
.299
1.077
1
1.043
Gender (male)
-.709 .659
.282
1.160
1
.492
Education: Less than High
.696
.015*
5.956
1
.183
School (versus More than HS)
1.699
Education: High School Only
.685
.095
2.793
1
.318
(versus More than HS)
1.145
Employment (employed)
.277 .664
.677
.174
1
1.319
Positive Social Interaction
.504 .240
.036*
4.413
1
1.656
Subscale
*p <.05; R2=.235
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Summary of Results
To answer the four research questions presented in this study, logistic regression analysis was
conducted to examine the impact of three independent variables, traumatic stress, mental health
symptom severity, and prosocial support on drug court graduation, controlling for four demographic
variables: age, gender, education, and employment. Prosocial support was further examined by four
subscales: emotional support, tangible support, affectionate support, and positive social interaction. The
results demonstrated that the majority of the demographic covariates were not predictors of drug court
graduation. However, a higher level of education, specifically having at least some college, was found to
be associated with successful completion of medication-assisted drug court treatment when compared
to those participants who had less than a high school education.
Research question two examined the relationship between traumatic stress experiences at
baseline and the dependent variable of drug court graduation and found no significant relationship.
Additional regression analyses were conducted using a recoded variable and an alternative measure of
trauma and results were still insignificant.
Research question three examined the relationship between mental health symptom severity at
baseline and drug court graduation; the relationship was not significant. Research question four
examined the relationship between access to prosocial support at baseline and drug court graduation;
the results were significant. Additional logistic regression analyses were conducted to examine different
types of prosocial support using the subscales of the measure and found that emotional support,
affectionate support, and positive social interaction were significantly related to drug court graduation,
whereas tangible support had no impact on drug court graduation. The implications of these results are
addressed in the discussion.
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Chapter 6: Discussion
The study of drug court processes and outcomes has garnered increased attention within the
research literature (Belenko, 2001; Dannerbeck, Harris, Sundet, & Lloyd, 2006; Finigan, 2009; Mitchell,
Wilson, Eggers, & MacKenzie, 2012; Zweig, et al., 2011). To expand consideration of the factors that
influence drug court graduation, this dissertation examined three independent variables deemed
relevant to graduation from medication-assisted drug court treatment. This study explored the
association of trauma experiences, mental health symptoms, and social support, while controlling for
four demographic variables (age, gender, employment, and level of education), with drug court
graduation. Evaluations of drug court outcomes have provided evidence that participation in such
programs is beneficial for society and offenders in terms of recidivism, relapse, and related cost savings
(King & Pasquarella, 2009; Marlowe, 2010; Rossman, Roman, Zweig, Rempel, & Lindquist, 2011; Sechrest
& Shichor, 2001: Taxman & Bouffard, 2002 ). However, the majority of outcome studies have focused
on structural-level processes within the court system that produce these effects with little examination
of individual-level effects. In particular, investigation of psychosocial factors remains largely unexplored.
Furthermore, research examining opioid offenders and medication-assisted treatment within drug
courts is scarce, despite rapidly increasing rates of the nonmedical use of prescription drugs. This
research adds to the literature on drug courts, as well as to the literature on nonmedical use of
prescription drugs, by including measures of psychosocial factors in an analysis of drug court graduation
among medication-assisted drug court treatment clients. The results of this analysis indicate that preprogram factors in terms of certain demographic characteristics (education level) influence successful
drug court completion and that social support is an important predictor of drug court graduation.
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However, the effects of other demographic characteristics (age and employment) and psychosocial
factors (trauma and mental health symptoms) had no impact on drug court graduation.
Demographic Variables – Findings and Implications
The first research question of this study focused on describing the demographic characteristics
of the sample in terms of age, gender, education level, and employment at baseline assessment in
comparison to drug court graduation. The literature documents these factors as being predictive of
drug court outcomes, albeit with inconsistent results. Previous research findings have supported the
suggestion that younger drug court clients are less likely to successfully complete drug court programs
(Dannerbeck, Harris, Sundet, & Lloyd, 2006; Hickert, Boyle, & Tollefsen,2009; Logan, Williams, Leukefeld,
& Minton, 2000; Saum, Scarpitti, & Robbins, 2001), while another study found that younger participants
were more likely to graduate (Senjo & Leip, 2001). Others researchers found no age effect (Gray &
Saum, 2005; Miller & Shutt, 2001). The average age of drug court clients in this sample was 28 for those
participants who graduated and 26 for those who did not graduate; this is consistent with national rates
that found mean ages (when reported) between 28 and 33 (Brown, 2010) . Consistent with some
research findings (Roll, Pendergast, Richardson, Burdon, & Ramirez, 2005; Schiff &Terry, 1997), age was
not a significant predictor of drug court graduation in this study and was not correlated with the other
variables in the study.
Within the criminological research, there is the theoretical notion of a developmental course of
criminal behaviors with some researchers positing the existence of career criminals (Blumstein& Cohen,
1979; Piqero, Farrington, & Blumstein, 2003), others differentiating life course persistent versus
adolescent limited offending behaviors (Moffitt, 1993, 1994), and still others stating that all offenders
will eventually age out of criminality (Hirschi and Gottfredson, 1983; Sampson & Laub, 2003). The only
consensus as to the age-crime relationship is that there seems to be some type of both individual-level
and contextual-level correlates operating to continue with or desist from further criminal behavior and
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that examining within-individual continuity over time is important to understand this relationship
(Loeber, Farrington, Stouthamer-Loeber, Moffitt, & Caspi, 1998; Moffitt & Caspi, 2001; Sampson &
Laub, 2003). Comparable to the criminological literature, a tangible method through which age could be
operating on drug court graduation is unclear from the larger body of drug court research and
impossible to determine from the results of this study. The lack of an effect from age could be due to
the small amount of variation in age among clients in this particular drug court. Given the inconsistent
findings within drug court research for age as a predictor of drug court graduation, research should
continue to examine this factor, particularly in relation to other variables and with a stronger theoretical
background to determine links. Moreover, longitudinal studies of long-term recidivism and relapse rates
after drug court graduation are scarce within the literature and this type of study could better explain
age effects.
Another perspective on the age-crime relationship within the criminological literature is that of
Sampson and Laub (1993), who suggested that the association is a function of participation within
conventional institutions within society, such as marriage and employment. Future studies should
consider if an age effect is present while controlling for other individual and contextual level factors.
Furthermore, age is in important factor in the nonmedical use of prescription drugs, with younger
individuals more likely to misuse and abuse pharmaceuticals than older individuals (Herman-Stahl,
Krebs, Kroutil, & Heller, 2007). Further research should examine age as a factor among NMPDU
populations and how that might impact use patterns, criminal justice experiences, and treatment
outcomes. For example, within the criminological literature, Ford & Schroeder (2009) examined NMPDU
in a college sample and identified general strain theory as supporting findings of use patterns; future
studies should expand on this and apply criminological theory to recent trends in drug use and crime to
better explain drug court outcomes. A stronger theoretical examination of pathways of the drug-crime
relationship in reference to NMPDU could have important practical benefits in terms of criminal justice
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processing, i.e., assessing risk and protective factors for criminal behavior could impact alternative to
sentencing programs and treatment options within a drug court framework.
In addition to examining age as a demographic factor predictive of drug court graduation, the
role that gender plays in successful drug court treatment was also explored in this study. Bivariate
results indicated a gendered effect in terms of drug court graduation, with more women successfully
completing the program than men; however, when other demographic factors were controlled for in the
statistical model, this finding was no longer relevant. Within the drug court literature, findings are again
mixed in terms of the effect of gender on graduation. Some research suggests that female drug court
participants have better outcomes than male participants (Gray & Saum, 2005; Dannerbeck, Harris,
Sundet, & Lloyd, 2006 Hartman, Johnson Listwan, & Koetzle Shaffer, 2007), while others have found no
differences between male and female participants in terms of drug court outcomes (Brown et al., 2011;
Evans et al., 2009; Peters et, al., 1999; Rempel et, al., 2003; Young & Belenko, 2002). Some studies have
indicated that female drug court participants are more motivated to complete treatment than their
male counterparts and others have suggested that women experience unique external factors that
influence drug court graduation, such as the threat of losing custody of their children (Dakof et, al.,2010;
Webster et al., 2006), childcare issues that impact treatment (Butzin, Saum, & Scarpitti, 2002), and lack
of specific services directed at women (Schaffer, Hartman, & Listwan, 2009).
Feminist perspectives within the criminological literature propose gendered pathways of crime
and deviance, which in turn affect rehabilitative outcomes. Daly (1994) proposes five pathways to crime
for women, all of which incorporate psychosocial factors: street women characterized by extensive
criminal histories, abusive childhoods, lower levels of education, and involvement in the welfare system
(Daly, 1994 Morash, 2006), harmed/harming women characterized by experiences of physical and/or
sexual abuse and/or neglect, with related psychological problems and a lack of coping skills that lead to
substance abuse and violence (Daly, 1994; Morash, 2006); battered women characterized by limited
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criminal histories with substance abuse often preceded by traumatic experiences (Daly, 1994; Leverentz,
2006; Morash, 2006); drug-connected women characterized by substance abuse that is highly impacted
by their interpersonal relationships with men who lead them into drug use and crime (Daly, 1994;
Morash, 2006); and economically motivated women characterized by criminal activities based on greed
or poverty (Daly, 1994). These pathways to criminal behavior for women could also impact treatment
outcomes without specific programming that addresses their particular criminogenic risk and protective
factors. The literature on rehabilitative procedures and evidenced-based practices is slanted toward
males with less attention given to the determination of effective interventions for female offenders
(Belknap, 2007; Hubbard& Matthews, 2008; Palmer & Hollin, 2007). An examination of gender-specific
or gender-responsive needs could better explain gender effects of drug court graduation as well as their
correlation with other variables. Utilizing feminist perspectives within criminological theory to further
study drug court clients could influence more research on gendered treatment programming and drug
court outcomes.
Additional investigation of recent trends in the drug-crime relationship in regard to gender could
yield more specific information important to recent trends in drug use patterns. The criminological
literature notes that men commit more crime than women (Steffensmeier, 1996; Lauritsen, Heimer, &
Lynch, 2009); however, women are more likely to be arrested for drug crimes than any other crime
(Bloom, Owen, & Covington, 2005). Furthermore, although men and women share some of the same
traits in terms criminality, such as lower socioeconomic status, lower levels of education, and
problematic interpersonal relationships (Liang & Long, 2013; Heimer, 2000), certain factors are more
likely to predict criminal behavior among women than men (histories of abuse, trauma experiences, and
mental health issues) (Belknap, 2001; Chesney-Lind & Pasco, 2004). These gender-sensitive factors
could also impact drug use patterns and treatment outcomes for women and require further
investigation within the drug court literature. Lastly, the literature on the role of gender and the
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nonmedical use of prescription drugs indicated varied results (McCabe, Teter, Boyd & Knight, &
Weschler 2005; Weyandt et al., 2009) and deserves further attention to assess the impact of gender on
drug court graduation among this population
A recent meta-analysis of drug court outcomes indicated a relationship between employment
and drug court performance (Zweig, et al., 2011). The results of this study did not support this finding.
Employment status did not significantly predict drug court graduation. However, given research within
the drug court literature as well as in the behavioral healthcare literature that indicates that this is an
important factor in treatment outcomes, future studies should examine this factor to determine its
utility in drug court programming. The lack of an employment effect in this study could be a result of
the participants having high levels of access to prosocial support systems; clients could be focusing on
treatment while being supported in ways that negate an influence of employment status.
Similar to the other demographic variables studied, level of education and drug court outcomes
demonstrate mixed findings in the research. The majority of studies find a positive relationship
between higher levels of education and drug court performance (DeMatteo et al., 2009; Hickert et. al,
2009; Mullany & Peat, 2008; Shaffer et al., 2010; Schiff & Terry, 1997); the results of this study are
consistent with these findings. Drug court clients in this study with higher levels of education were
more likely to graduate from drug court than those clients without a high school diploma. Some of the
drug court literature has produced findings with no education effect (Senjo and Leip, 2001a; Hepburn &
Harvey, 2007; Hiller et al., 1999), and future studies should examine whether controlling for other
significant variables accounts for the discrepancies. However, the education effect remained constant in
this study even when other demographic factors were included in the model; nonetheless, other factors
that were not included in these analyses could account for some variation. For instance, criminological
research demonstrates links between socioeconomic status and level of education that influences
criminal behaviors and this association could influence this relationship among drug court clients.
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Future studies should include socioeconomic status and criminal histories when examining level of
education as a predictor of drug court outcomes.
It should be noted that race was not examined in this study due to insignificant variance for this
demographic among the sample. However, history has shown that certain criminal justice policies and
rehabilitative correctional practices have led to disproportionate arrest rates and unequal access to
resources for racial and ethnic minorities (and class and gender inequalities as well) (Lutze,&
VanWormer, 2007) and drug court findings on race follow this trend. Within the drug court literature,
numerous studies have examined the relationship between race and drug court outcomes and found
significant differences between graduation rates of white and non-white drug court clients (Belenko,
2001; Fradella, Fischer, Kleinpeter, & Koob, 2009; Hartley & Phillips, 2001). Dannerbeck and colleagues
(2006) found that white drug court clients were more likely to graduate from drug court (55%) than
black drug court clients (28%). Belenko’s (2001) meta-analysis on drug court outcomes also found that
whites are more likely to have successful drug court outcomes than non-whites, but there is a lack of
consensus in the literature as to why this race effect is found. Race is an important topic within the
drug-crime literature and should be further examined among drug court participants and NMPDU
offenders in particular. The “war on drugs” contributed to disproportionate arrest rates among black
males for drug offenses (Beckett, Myrop, Pfingst, & Bowen, 2005; Beckett & Sasson 2004; Blumstein,
1993; Reinarman and Levine 1997). These patterns increase every year, yet the rates of black drug
offenders participating in drug court programs remains historically lower than the rates of white
participants (Fradella,Fischer, Kleinpeter, & Koob, 2009; Miller & Shutt, 2001; Sechrest & Shicor, 2001).
Underlying factors related to social disorganization, racism and poverty, and pathways to drug of choice
could be influencing criminal justice responses to black drug offenders. Individual-level predictors of
drug use patterns (Baumer, 1994; Duster, 1997) and drug court participation (Dannerbeck,-Kanku, &
Yan, 2009; Huebner & Bynum, 2008) could be tied to these types of contextual factors. Specifically,

67

neighborhood context and law enforcement attitudes about race, drugs, and crime (Goode, 2002) could
be influencing participation rates. Research on drug court outcomes has largely excluded contextual
factors and this should be given more consideration in the literature. Other confounding factors, such
as criminal history, level of education, and employment, and their links to race, have influenced drug
court outcomes (Belenko, 2001; Brewster, 2001; Schiff & Terry, 1997) and these issues should be further
explored.
Demographic characteristics play an important role in drug court outcomes despite a lack of
agreement among research findings (see Appendix A). Further exploration of these factors could have
important policy implications in terms of programming. For instance, Payton and Gossweiler (1999)
proposed that that a major problem among drug courts is the deficiency of specific, responsive
programs in regard to race, gender, and mental illness; MAT could be added to this issue. Drug court
programs that set specific selection criteria, detail protocols for adjudication and treatment, and offer
specialized means of supervision based on empirical findings in relation to individual level factors could
dramatically change what we know about for whom drug courts work for and why.
Independent Variables – Findings and Implications
In addition to an examination of demographic variables in this study, the prediction of drug
court graduation among medication-assisted treatment clients was examined by means of trauma
experiences, mental health symptoms, and access to prosocial support systems; the only effect found
was that of social support. The literature on psychosocial factors as being predictive of drug court
outcomes is scarce despite an expansive body of literature that documents significant associations
between trauma and mental health factors and substance abuse (Hawkins, Catalano, Miller, 1992;
Hasin, Goodwin, & Stinson, 2005; Jacobsen, Southwick, & Kosten, 2001; Triffelman, 2003) and
information that indicates high rates of mental health issues among on drug court participants (Cooper,
1997; Dannerbeck, Sundet, & Lloyd, 2002; Hagedorn & Willenbring, 2003). Additionally, the extant
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literature demonstrates associations between improved treatment outcomes and social support
(McLellan, Arndt, Metzger, Woody, & O'Brlen, 1993). Information on MAT drug court participants is
even less examined in the drug court literature, especially in regard to psychosocial factors as predictors
of graduation. There is, however, some research that examines psychosocial factors in relation to
NMPDU, and results indicated that NMPDU was associated with social phobias, depression, and anxiety
(Becker, Sullivan, Tetrault, Desai, & Fiellin, 2008). Studies also found gendered effects for NMPDU, with
women more likely to exhibit mental health symptoms than men (Brady, Back & Greenfield, 2009).
The aim of the second and third research questions for this study was to examine these
particular psychosocial factors to determine their impact on drug court graduation. The guiding
hypotheses were that experiences of traumatic stress and mental health symptom severity would have
a negative effect on drug court graduation. However, statistical analyses found no significant
relationship between trauma experiences or mental health symptoms of medication-assisted drug court
treatment clients and drug court graduation. These results are inconsistent with prior research in this
area, which indicates that these factors may impact treatment outcomes for both MAT and psychosocial
protocols (George & Krystal, 2000). The lack of an effect of these psychosocial factors on drug court
graduation could be due to the limitation of using only baseline assessment data, meaning that changes
could occur over time that influence graduation. Another explanation is that the measures used in the
study, particularly the TSS, are presented in a way that makes the import of the questions easy to
determine, which increases the possibility of participants providing social acceptable or biased
responses.
The lack of a trauma effect or a mental health effect could also be a function of the treatment
program incorporating mental health services within addiction treatment to improve client outcomes.
Lastly, there are more sophisticated measures of trauma available, and future research should examine
more comprehensive measures for review. Additional investigation should employ different measures
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to substantiate or refute this study’s findings. There are several explanations as to why a different
trauma measure may account for the lack of significant results. First, the TSS measures symptoms
related to past traumatic experiences within the last month, whereas participants at the baseline
assessment may have been focused on their current criminal justice situation and/or current mental
health issues and felt those factors to be a greater burden at the time than the way trauma had affected
them in the past. Secondly, it could be that assessing trauma and mental health symptoms in relation to
drug court graduation is a more complex issue than a simple model measuring only current symptoms
can account for. A more sophisticated longitudinal model using more sensitive measures, such as a
more comprehensive measure of trauma and/or qualitative methods, and a consideration of other
factors such as therapeutic alliance (collaborative aspect of the counselor/client relationship) (Bordin,
1979) in conjunction with these issues could better account for the nuances inherent in these types of
interpersonal problems. The literature strongly suggests that treatment outcomes are negatively
influenced by traumatic experiences and mental health symptom severity; even though the findings of
this study do not support the association between traumatic experiences and mental health issues,
more studies should examine these issues within a drug court context and in connection with the drugcrime relationship to expand our knowledge in these areas and to incorporate an interdisciplinary
approach that integrates criminological research within a behavioral healthcare perspective. For
example, criminologists are beginning to investigate ways to interpret psychosocial factors in relation to
nonmedical use of prescription drugs within existing criminological theories, such as general strain
theory (Ford & Schroeder, 2008). An examination of psychosocial factors that are specific to MAT and
NMPDU is imperative as the results of a single study cannot determine the scope of this issue. More
research is needed to better account for drug court applications that incorporate growing trends of illicit
drug use and its treatment.
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Criminology can contribute to this body of literature by incorporating factors related to
substance abuse within existing theoretical frameworks in the same vein as Ford & Schroder (2008).
General Strain Theory (GST) (Agnew, 1992, 1995, 2002, 2006) appears to offer a constructive theoretical
framework for explaining the factors associated with individual experiences of strain and substance
abuse. The experience of strain (stressors or trauma) as discussed in GST can be thought of as a distal
cause of crime; it is through the processes of mediation and conditioning that deviant or criminal
behaviors ultimately occur (Piquero and Sealock, 2004). Negative affect is presented as mediating the
relationship between strain and crime, while other variables condition strain’s effect on crime. The
emotion of anger is principally related to criminal acts and emotions related to depressive and trauma
related disorders for instance, despair and hopelessness, are related to deviant coping mechanisms such
as the use of drugs and/or alcohol (Agnew, 1992, 2001, 2006). GST allows for the examination of the
stressors that may contribute to substance abuse and subsequent criminal behaviors surrounding
substance abuse. Further exploration of integrating criminological theory with behavior healthcare
issues could lead to a better understanding of the impact of mental health on the drug-crime
relationship.
The final research question in this study examined the relationship between access to prosocial
support systems and drug court graduation. Results indicated a significant association with higher levels
of access to prosocial support predicting graduation. Overall social support, emotional support,
affectionate support, and positive social interaction were significantly related to drug court graduation,
whereas tangible support had no impact on drug court graduation. These findings are consistent with
the literature that demonstrates improved treatment outcomes for individuals with support systems
available compared with those individuals who do not have these resources (Davis & Jason, 2005; ElBassel, Chen, & Cooper, 1998; Gearon, Nidecker, Bellack, & Bennett, 2003). Research on social support
and drug court outcomes are limited and this finding contributes to the literature in this area. Behavioral
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healthcare research establishes a link between perceived social support and improvement in
psychosocial functioning during treatment (Chong & Lopez, 2005; Laudet, Cleland, Magura, Vogel, &
Knight, 2004; Warren, Stein, & Grella, 2007); this information is useful in adopting treatment strategies
and drug court programming to improve client success. Additional research on social support and drug
court outcomes should investigate the relationships among perceived social support, therapeutic
alliance, mental health symptoms, and traumatic stress experiences to determine if there are
interactions between these variables.
Social support networks are featured in several criminological theories that propose a link
between these associations and crime (Agnew, 1992; Akers, 1998; Capowich, Mazzerolle, & Piquero,
2001; Cullen & Wright, 1997; Thornberry, Lizotte, Krohn, Farnworth, & Jang, 1994; Warr, 2002), but few
studies directly discuss the concept of social support as a criminogenic factor. For example, general
strain theory (Agnew, 1992, 2000, 2002, 2006) implies that social support could prevent crime by
mediating the effects of negative affect that causes criminal behavior. In Sampson and Laub’s (1993)
life-course theory of crime, social bonds are discussed as providing “divergent pathways” from crime
(p.141). Conversely, differential association theory (Sutherland, 1947 see for e.g. Williams & McShane,
2004) and social learning theory (Akers, 2009) argue that criminal behavior is learned via social
interactions.
Exploring social networks within the current trends of the drug-crime relationship could have
important implications for drug-crime interventions. Future research should examine the effects of
social support on long-term recidivism and relapse as this determination could be important in providing
a better understanding of the drug-crime relationship. In fact, Francis Cullen proposed examining social
support as an organizing concept within criminological theory in his presidential address to the Academy
of Criminal Justice Sciences in 1994 (Cullen, 1994). Cullen states “… in criminology the insights linking
social support to crime remain disparate, and are not systematized so far as to direct theoretical and
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empirical investigation” (p. 529 ). Unfortunately, almost 20 years later this remains the case. Perhaps a
governing research direction, such as social support within the drug-crime relationship and its
subsequent outcomes can inspire the field to adopt Cullen’s proposed steps to include the study of
social support within criminology.
Limitations
This study has a number of limitations. The data were collected as part of an evaluation of a
single drug court program; there was no comparison group against which the data could be weighed.
Therefore, any conclusions generated by the outcomes of this study may apply only to this specific
population with negligible generalizability to drug courts overall. However, there are very few drug
courts utilizing medication-assisted treatment (MAT) and subsequently not much extant literature
examining this population. A conventional drug treatment court or use of a mental health court as a
comparison group would not have been feasible since these other types of courts would lack the MAT
component.
Another issue with generalizability is the relatively small sample size. Participants in this type of
drug court are rare, given the eligibility requirements. Further attrition from the sample caused by
declining to participate in the study or by active ongoing participation in drug court treatment did not
adversely affect the study, however. Analysis showed that the excluded sample (N=55) did not
significantly differ in demographic characteristics from the included sample.
Another limitation was the use of only baseline measures to predict later drug court outcomes.
Measurement of the independent variables at a single point in time cannot elucidate how drug court
processes and treatment over time could affect outcomes. Additionally, the use of secondary data
analysis can be problematic due to data quality issues (Law, 2005). For example, one shortcoming of
self-report data is that some participants may not have disclosed instances of trauma and mental health
symptoms, limiting the validity and accuracy of the data.
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Finally, there were limitations in the statistical analysis regarding the treatment of non-normally
distributed variables. Even though there are no assumptions about the distribution of independent
variables in logistic regression given that the focus is on the outcome variable (Agresti, 1996; Press &
Wilson, 1978), statistical procedures could be applied that further address the skewed distribution of
the data for trauma and mental health symptoms; trauma, in particular, had many zero values.
Statistical techniques to transform the data, for instance the Box-Cox (1964) transformation, might have
helped the data to obtain a more normal distribution using a mathematical method to check for the
smallest standard deviation. In this statistical technique, all data are transformed to a certain exponent
indicated by a Lambda value (Kim & Hill, 1993; Spitzer, 1982) and non-normally distributed data are
transformed to approximate normal distribution (Riani & Atkinson, 2000). This technique does not
always work and requires all items under comparison be transformed in the same way (Lindsey &
Sheather, 2010; Velilla, 1993). Given the small sample size and issues with the manner in which trauma
was measured, power transformation techniques were not applied. However, if further analyses are
completed with this data, these techniques should be considered.
Conclusion and Recommendations for Future Research
In conclusion, this study examined demographic characteristics and psychosocial attributes of
participants who participated in medication-assisted drug court treatment. The lack of significant
findings for trauma and mental health effects may possibly be a function of not controlling for other
significant variables; moreover, these data may not have sufficient measures of psychosocial factors,
particularly trauma, that demonstrates the relationship. Future studies on these issues would likely
benefit from more comprehensive measures and more sophisticated analyses. The significant models
found that higher levels of education and greater access to prosocial support were significant predictors
of graduation. Future research should continue to investigate these variables to better inform the
literature on the practical implications of these findings. The graduation rate for the selected MADCT
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sample was 76%, considerably higher than the national average of 51% (Huddleston and Marlowe, 2011)
indicating a positive outcome for drug court clients in medication-assisted treatment, an important
implication given the current trend of illicit drug use. This research validates that opioid-addicted
individuals can achieve treatment success. Implications for this particular court are examining policies
to retain participants with less than a high school education, such as improving literacy, and retaining
participants with less access to prosocial support systems, such as providing more social support
mechanisms within treatment options to further improve outcomes.
Drug court structure, approaches to treatment, and outcomes tend to vary widely, conditions
that have caused concern among many researchers as to the generalizability of any drug court findings
(Belenko, 2001; Nolan, 2001). However, generalizability may not be achievable and studies that
determine whether certain factors (individual or contextual) impact outcomes still contribute to the
literature in that common procedures that are then differently applied could be implemented based on
a larger body of research. For example, the inclusion of a risk assessment measure or measures of
mental health and trauma being consistently applied in drug courts overall would then influence site
specific programming that could improve outcomes for individual drug courts that would in turn inform
the aggregate research. Future research should consider a more comprehensive examination of not
only individual level factors, but also contextual level factors outside of drug court processes that could
influence outcomes.
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Appendix A: Extant Literature on Drug Court Outcomes
Demographics
Gender

Extant Literature
No gender differences:
 Evans, Li, & Hyser, 2009
 Hepburn & Harvey, 2007
 Marlowe, et. al, 2003
 Seachrest, & Shicor, 2001
 Senjo & Leip, ,2001
Males more likely to complete drug court:
 Belenko, 2001
Females more likely to complete drug court:
 Gray & Saum, 2005
 Dannerbeck, Harris, Sundet, & Lloyd, 2006
 Hartman, Johnson Listwan, & Koetzle Shaffer, 2007

Employment

Those employed more likely to complete:
 Butzin, Saum, & Scarpetti, 2002
 Zweig, et al., 2011
No age differences:
 DeMatteo, Marlowe, Festinger, & Arabia, 2009
 Gray & Saum, 2005
 Gallagher, 2013
 Miller & Shutt, 2001
 Roll, Pendergast, Richardson, Burdon, & Ramirez, 2005
 Shaffer et al., 2010
 Schiff &Terry, 1997
Older adults more likely to complete:
 Cissner & Rempel, 2005
 Hartley & Phillips, 2001
 Hickert, Boyle & Tollefson, 2009
 Hepburn & Harvey, 2007
 Young and Belenko, 2002
Younger adults more likely to complete:
 Senjo & Leip. 2001
Younger adults less likely to complete:
 Dannerbeck, Harris, Sundet, & Lloyd, 2006
 Hickert, Boyle, & Tollefsen,2009
 Logan, Williams, Leukefeld, & Minton, 2000
 Saum, Scarpitti, & Robbins, 2001

Age
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Demographics
Education level

Psychosocial Characteristics
Trauma

MH

Social support

Extant Literature
No education differences:
 Senjo & Leip, 2001
 Hiller, Knight, & Simpson, 1999
 DeMatteo et al., 2009
 Gray & Saum, 2005
 Hepburn & Harvey, 2007;
 Hickert, Boyle, & Tollefson, 2009;
 Schaeffer et al., 2010;
 Mullany & Peat, 2008;
 Schiff & Terry, 1997
Extant Literature
No studies specifically examine traumatic experiences in terms of
drug court outcomes, but the literature on treatment completion
indicates a negative relationship between traumatic stress
experiences and successful completion of treatment.
No mental health differences:
 Dematteo, Marlowe, Festinger, & Arabia, 2009
 Cosden, et al, 2006
More mental health symptoms less likely to complete:
 Cissner& Rempel , 2005
 Evans, Li, & Hser, 2009
 Garrity, et al, 2007
 Gray & Saum, 2005
 Hickert, Boyle, & Tollefson, 2007
 Hickert, et al, 2009
 Hiller, Knight, & Simpson, 1999
 Mendoza, Trinidad, Nochajaski, & Farrell, 2013
No studies specifically examine social support in terms of drug
court outcomes, but a large amount of literature on treatment
completion indicates a positive relationship between prosocial
support mechanisms and successful completion of treatment.
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